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Development of Novel Biocompatible Hydrogel Coatings  
for Implantable Glucose Sensors 
Chunyan Wang 
ABSTRACT 
Due to sensor -tissue interactions, currently none of the commercially available 
glucose sensors are capable of continuous, reliable monitoring of glucose levels during long-
term implantation.  In order to improve the lifetime of implanted glucose sensors, two series 
of biocompatible novel hydrogel coatings were designed, synthesized and the physical 
properties were measured.  
Different hydrogels with various 2,3-dihydroxypropyl methacrylate (DHPMA) 
compositions were coated onto glucose sensors. Results show that the higher freezable water 
content, swelling rate and uniform porosity that resulted from high DHPMA content 
increased the sensitivity and shortened the response time of glucose sensors.  The linear 
range of a glucose sensor coated only with hydrogel is short, however, the range can be 
improved by coating the epoxy- polyurethane (PU) with a layer of hydrogel.  Since the 
hydrogel minimizes the fibrosis and inflammation, it shows promise for use in implantable 
glucose sensors.  However, the in vivo experiment shows only 25% of sensors still worked 
after 4 weeks.  In order to overcome problems present in the first series of experiments, 
another series of novel hydrogels with various N-vinyl pyrolidone (VP) contents was 
developed.  This study has provided a feasible approach to design and select the properties 
 xix 
of the copolymer for coating implantable biosensors.  The in vivo experiments demonstrate 
that a hydrogel coating significantly improved the performance of implanted glucose sensors. 
In order to suppress the acute inflammation caused by the surgery, dexamethasone-21 
phosphate disodium salt (DX-21) was incorporated to a series of poly (HEMA-DHPMA-VP) 
hydrogels to investigate the drug delivery in vitro.  All hydrogels showed a high initial 
release, followed by slow, long term release during the next hours to days.  This release 
pattern is believed to be optimum for implanted glucose sensors suppressing the acute and 
chronic inflammation.   
Water structures in hydrogels swollen in different media water, PBS and DX-21 
solution were also investigated.  1HEMA:1DHPMA copolymer and VP-HEMA-DHPMA 
copolymers imbibed higher freezable water fractions in DX-21 solution.  The ratio of 
transporting water mass to DX-21 mass is 9.6 which is independent of the hydrogel 
composition. 
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CHAPTER 1 
INTRODUCTION 
The aim of this project is to design, synthesize and characterize novel 
biocompatible hydrogels for the coatings of implantable glucose sensors and drug 
delivery system to enhance implanted glucose sensors’ function and lifetime in vivo.  
This project has been funded by the National Institute of Health (NIH).  The 
research has been conducted under the supervision of co-PI, Dr. Julie Harmon of the 
Department of Chemistry (USF). 
1.1.  Diabetes 
Diabetes is a chronic disease which involves regulatory problems with the 
hormone insulin.  Insulin is released from the pancreas to regulate the amount of 
glucose in the bloodstream.  When the pancreas doesn’t produce the correct level 
insulin, or the body does not respond appropriately to insulin, the symptoms of 
diabetes occur.  According to American Diabetes Association (ADA), there are 23.6 
million children and adults in the United States, or 7.8% of the population, who have 
diabetes. (Diabetes, Oct.20, 2008)  
There are two types of diabetes.  Type 1 diabetes occurs when the 
insulin-producing cells of the pancreas (called beta cells) are destroyed by the 
  
2 
immune system.  People with type 1 diabetes don’t produce insulin and must use 
insulin injections to control their blood glucose level.  It is estimated that 5-10% of 
Americans who are diagnosed with diabetes have type 1 diabetes.  Unlike people 
with type 1 diabetes, people with type 2 diabetes produce insulin.  However, the 
insulin their pancreas secretes is either not enough or the body is unable to recognize 
insulin and use it properly.  When there isn't enough insulin or the insulin is not used 
as it should be, glucose can't get into the body's cells.  About 90 to 95% people with 
diabetes have type 2 diabetes. (Diabetes, Oct.21, 2008) 
Long-term high glucose levels can cause a number of long-term, sometimes 
life-threatening complications including heart disease and stroke, high blood pressure, 
blindness, kidney disease, nervous system disease, dental disease; therefore it is 
crucial to control and monitor the blood glucose level. 
1.2. Implantable Glucose Sensors 
In order to regulate the blood glucose concentration, it is important for 
diabetics to have the ability to monitor blood glucose concentration.  Diabetes 
patients are used to self-monitoring blood glucose levels by finger pricking to obtain 
blood samples.  This kind of monitoring is discontinuous since it depends on how 
frequently the blood glucose detection is performed.  It is very difficult to record 
frequent enough determinations every day because the patients are unwilling to 
withstand the pain associated with frequent finger pricking.  Currently, continuous 
glucose monitoring systems, glucose sensors, are being developed as an alternative to 
  
3 
the present method.  Glucose sensors can continuously detect changes of blood 
glucose levels, and therefore provide information on how to optimize insulin therapy 
and to control the patients’ metabolism. 
Since the first enzyme electrode was constructed for the measurement of blood 
sugar in the 1960s (Clark et al. 1962), considerable amount of research has been 
devoted to the development of glucose sensors.  Many kinds of glucose sensors have 
been studied including non-invasive glucose sensors such as optical glucose sensors 
or sensors designed to detect the glucose concentration in tears (Baca, 2006) or urine 
(Shieh, 1997), mini-invasive glucose sensors which can be implanted in the 
subcutaneous tissue, vascular bed(Armour et al. 1990; Frost and Meyerhoff, 2002) or 
transferring interstitial fluid outside the body and detecting by micro dialysis 
device(Steinkuhl et al. 1996).   A non-invasive glucose sensor is the most optimum 
method for patients and because it overcomes the biocompatibility problems.  
However the precision of this method needs to be improved for clinical applications.  
Micro dialysis needs recalibration at least once daily and has the time lag between 5 
and 45 min caused by the length and diameter of the tube and the rate of the pumping.  
Due to the risk of inserting the glucose sensor in the intravascular compartment for a 
long period, most studies have focused on the development of needle-type glucose 
sensors for subcutaneous glucose monitoring (Chen et al.1992; Matthews et al. 1988).  
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Figure 1.1 Schematic diagram of the sensor. Figure adapted from 
(Moussy et al.1993)  
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Figure1.1 shows the typical needle-type implantable glucose sensor which is a 
two electrode system including a central platinum (Pt) anode as working electrode and 
a silver/ silver chloride(Ag/AgCl) reference electrode surrounding around Pt anode.  
Glucose oxdiase(GOx) is immobilized between the coiled Pt electrode.  The entire 
sensor is coated with a Nafion membrane to protect other components from biological 
degradation.  Once glucose passes through Nafion membrane, in the presence of 
oxygen, it is oxidized by GOx and produces hydrogen peroxide (H2O2). Hydrogen 
peroxide is oxidized by a polarization voltage of about +700 mV at Pt electrode 
surface, thus producing an electric current that is monitored (Abel and von Woedtke, 
2002). The chemical reactions are: 
Glucose +O2 Gluconic Acid+H2O2
GOx
 
H2O2
700mV
2H+ + O2 2e-+  
In vitro and animal experiments initially showed encouraging results.  However the 
long-term stability of the signal is insufficient due to the low biocompatibility of the 
electrode surface.  
 
1.3. Biocompatibility of Implanted Glucose Sensors  
The implanted glucose sensors are not reliable if they progressively lose 
function after several days in vivo.  It is believed this is caused by the events that 
affect the sensor itself (e.g. degradation, fouling), as well as by changes in the tissue 
surrounding the sensor, caused by implantation (Moussy, 2000).  
  
6 
When glucose sensors are implanted within the body membrane, biofouling 
processes start immediately.  Low molecular weight solutes, such as ions, small 
organic molecules, and high molecular weight composites, such as proteins and 
enzymes, will deposit on the surface of the sensors.  Surface deposition of the low 
molecular weight solutes on the metallic electrodes, such as Pt, can cause degradation 
or corrosion of the metallic component.  These problems can be avoided by coating 
electrodes with polymers such as polyurethane, cellulose and cellulose acetate, and 
Nafion.  The initial step of protein adsorption could result in an unstable protein 
layer, which may alter or totally block the substrates’ transportation, and therefore 
diminishing sensor’s in vivo performance.  Once a protein layer has formed, cellular 
interactions occur with protein coated sensors shown in Figure1.2 (Fraser, 1997).  
These interactions lead to adhesion and activation of cells which characterize the 
inflammatory response.  In such a case the diffusion distance of the glucose and 
oxygen is greatly increased, and the true glucose concentration surrounding the 
implantation site is different from that in non-inflammed subcutaneous tissue (Rebrin 
et al. 1992). Pickup et al. (Pickup et al. 1993) reported protein and cellular 
accumulation on the tips of the non-functioned glucose sensors after only five hours 
of implantation.  Figure1.3 shows scanning electron microscopy (SEM) Photographs 
of Tips of Glucose Sensors.  The functioning sensor shows minimal biofouling, but 
the non-functioning sensor shows significant protein and cellular accumulation. 
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When substances from the body are able to penetrate the outer membranes and 
alter the metal electrode surface, electrode fouling, sometimes referred to as electrode 
passivation, occurs and causes a decrease sensor signal(Reddya and Vadgamab, 1997; 
Linke et al. 1999).  
In the case of fibrosis, the smooth solid sensors become surrounded by the 
fibrous capsule.  The fibrous capsule surrounding the sensor presents a structurally 
distinct barrier of collagen fibrils, which might have an effect on the substrate mass 
transport, resulting in a delay in sensor response and an underestimation of analytes. 
(Frazer, 1997) Figure1.4 shows dense fibrous capsule tissue surrounding a glucose 
sensor tip after 10 days of implantation in subcutis (Ertefai and Gough, 1989). 
 
 
Figure1.2 The initial protein adsorption is followed by cellular adhesion onto the 
protein-coated surface of the device. Figure adapted from (Voskerician and Aderson, 
2006) 
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Figure1.3 SEM photographs of tips of glucose sensors. (A) Control sensor not 
implanted; (B) Functioning sensor showing minimal biofouling; (C) Non-functioning 
sensor showing significant protein and Cellular accumulation. Figure adapted from 
(Pickup et al. 1993) 
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Figure1.4 Light micrograph image of glucose sensor tip after 10 Days of 
implantation in subcutis. Figure adapted from (Ertefai and Gough, 1989). 
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1.4. Strategies to Improve Sensor Biocompatibility 
It can be seen that modification of the interface between sensor and tissue to 
control inflammation and fibrosis will enhance a glucose sensor’s biocompatibility, 
function and lifespan.  Thus strategies to improve sensor biocompatibility include 
modifications to reduce protein adsorption and local drug delivery of tissue response 
modifiers.  
Modifications to Reduce Protein Adsorption 
Protein adsorption is controlled by the characteristics of the material including 
topography, charge density, distribution and mobility, surface groups (chain length, 
hydrophobicity, and hydrophilicity), structural ordering (soft to hard segment ratio 
and distribution), and the extent of hydration(Wisniewski et al.2000), therefore the 
simple strategy to improve sensor biocompatibility is to reduce protein adsorption by 
surface modification.  One approach to modify the surface of glucose sensors is to 
incorporate poly (ethylene glycol) (PEG) into a poly(hydroxyethylmethacrylate).  
The PEG chains tend to line up parallel to each other and perpendicular to the surface 
to present a water rich phase that resists penentration by many proteins (Claesson, 
1993).  Compared to the same membranes without PEG, PEG in the outer membrane 
induced less fibrous encapsulation after subcutaneous implantation in rats.  But there 
is no report about improvement in sensor performance (Quinn et al. 1995; Quinn et al. 
1997).  
The diamond-like carbon (DLC), so-called ―inert‖materials are also used to 
coat on glucose sensors to enhance hemocompatibility as determined by both 
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sensitivity change and surface deposition of blood components examined by SEM. 
(Higson and Vadgama, 1995).  
Another strategy to reduce protein adsorption is to develop biomimetic 
coatings containing phosphorylcholine (PC) groups.  It has been demonstrated that 
PC coated glucose sensor could diminish protein adsorption (Yang et al. 2000).  One 
example of making biomimic membrane is to self-assemble phospholipids on the 
polymer surface containing a phosphorylcholine group, 2-methacryloyloxyethyl 
phosphorylcholine (MPC) and hydrophobic alkyl group.  The surface shows an 
excellent resistance for both protein adsorption and blood cell adhesion.  The relative 
output current of the sensor covered with this membrane was maintained as the initial 
level even after 14 days of subcutaneous implantation in a rat (Ishihara, 2000).  
Other methods to reduce protein adsorption include the use of alginate/ polyly- 
-sine gel (Shichiri et al. 1988), PHEMA/polyurethane (PU)(Shaw et al. 1991), 
NafionTM (perfluorosulphonic acid) membrane(Wilkins et al. 1995; Moussy et al. 
1994), crosslinked albumin(Armour et al. 1990), cellulose(Kerner et al. 1993).  
Local Drug Delivery Strategies 
Site specific, controlled delivery of tissue response modifiers can be used 
alone or combine with above surface modifications to help control the tissue reaction.  
The anti-inflammatory drug dexamethasone (DX) contained in microspheres is 
incorporated into a hydrogel and coated onto glucose sensors.  The in vivo 
experiment results show that eluting dexamethasone successfully controled negative 
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tissue reactions at the sensor-tissue interface by reducing the level of 
inflammation-mediation cells to those observed in normal tissue (Patil et al. 2004; 
Norton et al. 2005). 
Controlled nitric oxide (NO) or vascular endothelial growth factor (VEGF) delivery 
also can suppress the tissue reactions and improve biosensor performance(Norton et al. 
2005; Shin and Schoenfisch, 2006).  
 
1.5. Hydrogel  
Hydrogels are three- dimensional cross-linked polymer networks which are 
designed to swell but not dissolve in water.  They can be chemically cross-linked by 
a covalent bond with multi-functional cross-linkers or physically cross-linked by 
physical cross-links from entanglements, association bonds such as hydrogen-bond, 
Van der Waals forces, hydrophobic forces or crystalline forces (Peppas, 1986, V1).  
Due to high water absorption, low interfacial tension, high permeability to 
small molecules, and the soft and rubbery nature, hydrogles are well suited for 
biomaterials. Therefore, the biomedical applications of hydrogels, such as sutures, 
contact lenses, and drug delivery vehicles are of most interest.  Table 1.1 lists some 
biomedical applications of hydrogels summarized from Peppas’Book (Peppas, 1986). 
 
 
 
  
13 
Table 1.1 Some biomedical applications of hydrogels 
Biomedical 
applications 
Example  Materials 
Blood compatible 
applications 
Poly(vinyl alcohol)(PVA), Polyacrylammide(PAAm), 
Poly(N-vinylpyrolidone)(PVP),Poly(hydroxyl-methacrylate)(P
HEMA), poly(ethylene, oxide)(PEO), Poly(ethylene 
glycol)(PEG), cellulose 
Contact lenses 
PHEMA, P(VP-co-HEMA), acrylamide and acrylonitrile 
based hydrogels, P(HEMA-co-MMA) 
Artificial tendons Fiber (polyethylene terephathalate) reinforced hydrogel 
Controlled release 
devices 
PHEMA, P(HEMA-methyl acrylate) copolymers, 
P(HEMA-MMA)copolymers, P(HEMA-polymethacrylic acid) 
copolymer, PVA, PVP,  
Membranes for 
biomacromolecular 
separations for 
plasmapheresis, 
artificial kidneys, 
artificial liver 
P(glycerolmethacrylate-co-MMA),P(Hydroxypropyl 
methacrylate -MMA), pure PHEMA, PVA, PVP 
sutures PHEMA 
Artificial skins PVA-formaldehyde foam, PHEMA 
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Hydrogels commonly are classified into neutral hydrogels, ionic hydrogels and 
swollen interpenetrating polymeric networks (IPN).  Neutral hydrogels are based on 
neutral monomers, while ionic hydrogels are based on the ionic monomers such as 
acryl acid, methacrylic acid.  An interpenetrating polymer network (IPN) is a 
combination of two polymers one of which must be synthesized, or crosslinked in the 
immediate presence of the other.  For an interpenetrating polymeric network (IPN) 
hydrogel system, there is no chemical bonding between two polymer networks, but 
there are physical entanglements (Liu et al. 2003 ).  Covalent crosslinked gels do not 
dissolve in organic solvents even upon the addition of heat; whereas non-covalent 
crosslinked gel will eventually dissolve in solvents or melt upon the addition of heat 
(LaPorte, 1997). Thus physically crosslinked gels are not stable in heat and solvent 
environment.  The properties of synthetic hydrogels can be controlled by chanaging 
the ratio of hydrophilic to hydrophobic monomers.  Neutral hydrogels are more 
biocompatible than the ionic hydrogels since more proteins will absorb on the surface 
of ionic materials (Peppas,1986), and crosslinked neutral hydrogels are more stable 
than the interpenetrating hydrogels.  In this project the neutral hydrogels are 
polymerized for the sensor coatings because the nonionic hydrogels exhibit minimal 
protein build-up and excellent pH stability (Gates and Harmon, 2001).  
Some common synthetic hydrogels being used as biomaterials include 
PHEMA, poly(2,3-dihydroxypropyl methacrylate) (PDHPMA)), PAAm, PVP, and 
PVA.  
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Poly(hydroxyalkyl methacrylates)(PHEMA) Hydrogels 
PHEMA is the most studied hydrophilic polymer in the biomedical industry. 
Since Wichterle and Lim polymerized HEMA hydrogels in 1960(Wichterle and Lim, 
1960) for contact lenses, PHEMA hydrogels have received a lot of interest.  
The biocompatibility of PHEMA hydrogels is primarily due to high water 
content absorbed into the hydrogel network.  Initiators, reaction by-products, 
residual monomer, and impurities can be extracted with successive aqueous washings, 
so the likelihood of toxic or local immune reactions decreases in biomedical 
applications.  When used as an implant, the rubbery nature of the hydrated hydrogel 
reduces mechanical irritation of surrounding tissue.  The low interfacial tension 
between the hydrogel surface and aqueous solution minimizes protein adsorption and 
possibly cell adhesion (Ratner and Hoffman, 1976).  
Cross-linker impurities are present in all methacrylate monomers, so it is usual 
to obtain crosslinked gel instead of linear PHEMA.  PHEMA hydrogels can be 
prepared by bulk polymerization or solution polymerization using heat initiators or 
photoinitiators.  The most popular method for preparing PHEMA hydrogels is by 
solution polymerization of the monomer, HEMA, in the presence of a cross-linking 
agent.  Different solvents can be used for solution polymerization such as dimethyl 
sulfoxide(DMSO), propanol, glycerol, ethylene glycol, cyclohexanol, toluene, and 
dimethyl formamide.  Water is commonly used as a solvent in the preparation of 
PHEMA hydrogels.  Below a critical solvent concentration (40 to 60% water by 
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weight), the gel thus formed is homogeneous, nonporous, and optically transparent. 
When the solvent concentration is above this critical value, the resulting gel is 
heterogeneous and has a macro-porous structure, and is optically opaque (Laporte, 
1997). 
The water content of PHEMA hydrogels is usually relatively low(<45 wt%), 
which results in the limited applications of these hydrogels (Lee and Lin, 2003). 
Furthermore, PHEMA does not have the stringent mechanical properties needed for 
many biomedical applications. It was found that mechanical properties could be 
improved by crosslinking with ethylene glycol dimethacrylate(EGDMA).  Water 
content can also be increased by copolymerizing with other monomers such as DHPM 
or vinyl monomer, VP (Laporte, 1997). (Table 1.2) 
Poly(N-Vinyl-2-pyrolidone)(PVP) Hydrogels 
The backbone and ring structure of PVP provide hydrophobicity while the 
highly polar amide group provides hydrophilicity similar to that of a protein, but is 
physiologically inactive.  The size of VP repeating structure along the main carbon 
chain produces free volume in the material, resulting in flexibility and water solubility. 
PVP was first used as a blood plasma substitute and extender during World War II 
(Robinson et al. 1990) VP can also be copolymerized with other materials to modify 
properties for various medical applications (Laporte, 1997). PVP is a major 
component of some contact lenses and has been proposed as a material that can 
enhance blood compatibility (Francois et al. 1996).  
  
17 
PVP hydrogels have also been used as cell culture substrates.  
Interpenetrating polymer networks (IPNs) composed of PVP and gelatine have been 
studied as non-fouling materials for devices in contact with blood (Lopes and 
Felisberti, 2003).  It has been shown that 70% PVP exhibits optimum swelling 
degree and compression strength.  In biocompatibility tests, 70%PVP hydrogels 
showed no deleterious effect to the cells but were not good as gelatin for cell growth.  
As it turns out, 50% PVP retains the best properties of both polymers with higher 
water swelling degree, compression strength and biocompatibility.  Risbud et al. 
(Risbud et al. 2000) reported a growth promoting effect in a PVP-co-chitosan (a linear 
polysaccharide) hydrogel as compared to chitosan gels alone.  Janson et al. studied 
porous VP-BMA (n-butyl methacrylate) copolymers as scaffolds for bone tissue 
engineering.  In their study they reported that 50:50(VP: BMA) is less cytotoxic and 
more biocompatible than 70:30 counterpart in vivo (Janson et al. 2005).  From these 
research results, it can be concluded that VP can enhance the water content, 
mechanical properties and porous structures of hydrogels at the same time, behavior 
unusual for a hydrogel.  High VP percent hydrogels show less biocompatibility, but 
50% of PVP hydrogels are biocompatible.  Furthermore, PVP can be coated on the 
polyurethane surface and firmly attach to the surface (Francois et al. 1996).  This 
property is essential for this project. 
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Table 1.2 monomers’ structures and MWs 
Chemicals Structure Molecular Weight 
2-hydroxyethyl 
methacrylate(HEMA) 
CH3
CH2
O
OH
O
C
CH2
CH2
C
 
130.14 
2,3-dihydroxypropyl 
methacrylate(DHPMA) CH3
O
O
C
CH
CH2
OH
CH2
OH
CCH2
 
160.17 
N-Vinyl-2-Pyrrolidinone(V
P) 
 
111.14 
Ethylene 
dimethacrylate(EGDMA) 
 
198.22 
1-phenyl-2-hydroxy-2-meth
yl-propan-1-one (Benacure 
1173) 
C
O CH3
OHC
CH3  
164.00 
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Poly (2,3-dihydroxypropyl methacrylate) (PDHPMA)) Hydrogels 
In comparison with PHEMA, PDHPMA is more hydrophilic and even soluble 
in water since it contains two hydroxyl groups in each of its repeat units (Hou et al. 
2002).  DHPMA is often copolymerized with HEMA or VP to make hydrogels for 
soft contact lenses (Wang et al. US patent).  Clinical experiments show that 
hydrogels used as contact lenses will dehydrate especially at high water contents 
(McConville and Pope, 2001).  Gates found that DHPMA exhibits decreased water 
loss rate (Gates et al. 2003).  
Photopolymerization of Hydrogel by Ultraviolet light (UV) 
Polymerization of hydrogels can be initiated by γ radiation, heat or Ultraviolet 
(UV) radiation with initiators or they can self-initiate.  UV radiation is frequently 
used to induce cross-linking of polymers, because it requires less time, less energy, 
and generates little heat during polymerization (Laporte, 1997).  In addition, heat 
sensitive substrates such as plastics, printed circuit boards, paper, and wood can be 
coated and cured by UV (Nichols et al. 2001; Koleske, 2002).  
There are three main components in UV curing system: monomers or 
oligomers, photo-initiators and additives.  First, photo-initiators absorb high intensity 
UV light and are raised to an excited state. From their radiation-excited state, the 
photo-initiators photolyze or degrade directly or indirectly into free radicals.  These 
free radicals initiate the very rapid polymerization and crosslinking of monomers (Lee 
et al. 2006).  Steps of UV polymerization are listed in Figure 1.5. 
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According to the process for forming the initiating radicals, photo-initiators 
can be divided into two classes.  Norrish Type I photo-initiators (cleavage) photolyze 
through a homolytic fragmentation mechanism or through a-cleavage, and thereby 
directly form free radicals capable of initiating polymerization. (Figure1.6) 
Norrish Type II photo-initiators (H-abstraction) are activated with radiation 
and form free radicals by hydrogen abstraction or electron extraction from a second 
compound (coinitiator) that becomes the actual initiating free radical.  In addition, 
the Norrish Type II reactions are intra-molecular, so Type II photo-initiators are more 
easily affected by the environment such as oxygen and viscosity (Lee et al. 2006). 
The majority of Type I photo-initiators are aromatic carbonyl compounds 
which can carry out fragmentation by α-cleavage or β-cleavage.  The most important 
fragmentation in photo-initiator molecules is the α-cleavage of the carbon-carbon 
bond between the carbonyl group and the alkyl residue in alkyl aryl ketones 
(Figure1.7).  1-phenyl-2-hydroxy-2- methyl- propan-1-one (Benacure 1173) is a very 
popular photo-initiator (structure shown in Table 1) because it is highly reactive, 
thermally stable, does not yellow and can be used in water based formulations 
(Crivello and Dietliker, 1998).  
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Figure1.5 Various steps in a photoinitiated polymerization 
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Type I Photoinitiator: unimolecular fragmentation 
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Type II photoinitiator: bimolecular fragmentation 
Figure1.6 Types of photoinitiator. (Crivello and Dietliker, 1998) 
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Figure1.7 α-Cleavage of alkylaryl ketones.(Crivello and Dietliker, 1998) 
 
 
 
Previous investigations into the biocompatibility of PHEMA and PDHPMA as 
homo- and copolymers by UV polymerization showed that hydrogels containing 
80%DHPMA and 20%HEMA were found to induce minimal to no fibrosis when 
implanted subcutaneously in rats (Mohomed et al. 2006).  Unfortunately, as it sorbed 
large amounts of water, the mechanical stability of the high content DHPMA 
copolymers (80%DHPMA:20%HEMA) and the PDHPMA homopolymer decreased, 
and the samples were easily fragmented.  The biocompatible hydrogels were also 
coated onto the polyurethane (PU)/epoxy coated metal sensor by dip-coating, or in 
situ polymerization.  It was noted that the PHEMA coating easily delaminated from 
the PU/epoxy coating once swollen in water (Mohomed, 2006).  
To improve the lifespan of glucose sensors, the objectives of hydrogel 
coatings are: 
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1) the coating must allow glucose, oxygen and hydrogen peroxide to diffuse 
freely, while causing minimal fibrosis and inflammation. 
2) it should be easily coated onto the surface of implantable glucose sensors 
3) it should attach firmly and permanently to the glucose sensors and strong 
enough not to break during the implantation period. 
4) it must not deter the performance of the implantable glucose sensors. 
5) it should deliver anti-inflammatory drug and release drug to suppress both 
acute and chronic inflammatory.  
According to previous work by Mohomed, the formulations of hydrogel have 
based on HEMA and DHPMA copolymer for its excellent biocompatibility, but well 
modified with another monomer to improve the coating properties.  
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CHAPTER 2 
SYNTHESIS AND PEFORMANCE OF NOVEL HYDROGELS COATING 
FOR IMPLANTABLE GLUCOSE SENSORS  
2.1. Introduction 
State of the art implantable glucose sensors do not work reliably and have a 
short life after implantation (Moussy，2002).  This in vivo loss of function is caused 
by tissue reactions surrounding the sensor such as fibrosis and inflammation (Mang et 
al. 2005).  In order to improve the lifetime of implantable glucose sensors, the 
biocompatibility of the coatings must be monitored
 
(Gerritsen et al. 2000).  Many 
biocompatible coatings have been prepared for sensors such as hydrogels (Praveen et 
al. 2003; Galeska et al. 2001; JP 60171140; USP 5786439), silica-based hybrid 
materials(Kros et al. 2001), sol-gel coatings(Gerritsen et al. 2000), diamond-like 
carbon films and diamond-like carbon-coated anodized aluminum oxide nanoporous 
membranes(Narayan et al. 2007).  All of these coatings showed some potential for 
use in sensors, but formulations need to be optimized at this time. 
The outer interfacial coatings of implantable glucose sensors must be stable in 
biological fluids, ensure the transport of glucose to the sensors, resist the deposition of 
the proteins and other interferents and minimize fibrous encapsulation. Three- 
dimensional cross-linked polymer networks known as hydrogels have been shown to 
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meet these requirements and have the added benefit of swelling in water without 
dissolving (Praveen et al. 2003; Kros et al. 2001;Gerritsen et al. 2000).  
Poly(hydroxyethyl methacrylate) (PHEMA) hydrogels were first polymerized 
and studied for biological use by Wichterle and Lim in the early 1960s(Wichterle and 
Lim, 1960;Wichterle and Lim, 1961).  Since they are biocompatible, PHEMA 
hydrogels have been used in biomedical and pharmaceutical applications such as 
contact lenses, implants and drug delivery systems.  PHEMA was first used in 
glucose sensors by John Christopher, et al in 1990(Pickup and Claremont, 1990). 
Sensors coated with PHEMA were stable for 24hrs in vitro at 37℃.  However, much 
longer life times are required. PHEMA hydrogels are clear, exhibit smooth surfaces 
and are biocompatible (Rozakis et al. 2005).  Drawbacks of using PHEMA gels are 
that their mechanical properties are poor and equlibrium water contents are relatively 
low, <45 wt% (Lee and Lin, 2003); water uptakes of 200 wt% are needed for 
optimum operation (Van Antwerp et al. 1998). Mechanical properties can be 
increased by preparing PHEMA hydrogels with ethylene glycol dimethacrylate 
cross-linker(EGDMA). Equilibrium water contents can be increased by preparing 
PHEMA hydrogels with more hydrophilic monomers such as 2, 3-dihydroxypropyl 
methacrylate (DHPMA) (Yasuda et al. 1966; Macret and Hild, 1982) or N-vinyl 
pyrolidinone (VP) (Laporte, 1997). According to previous investigations of hydrogel 
(80%DHPMA:20%HEMA) coating for implantable glucose sensors, it was found that 
the biocompatibility and equilibrium water content are improved (Mohomed. 2006). 
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Unfortunately, as it sorbed large amount of water the mechanical stability of the high 
content DHPMA copolymers (80%DHPMA: 20%HEMA) decreased, and the samples 
were easily fragmented. The biocompatible hydrogels were also coated onto the 
polyurethane (PU)/epoxy coated metal sensor by dip-coating, or in situ 
polymerization. It was noted that hydrogel coatings easily delaminated from the 
PU/epoxy coating once swollen in water (Mohomed, 2006).  
Since PVP was first used as a blood plasma substitute and extender during 
World War II (Robinson et al. 1990), VP can be copolymerized with other materials 
to modify properties for various medical applications (Laporte, 1997). VP can 
enhance the water content, mechanical properties and porous structures of hydrogels 
at the same time, behavior unusual for a hydrogel.  High VP percent hydrogels show 
less biocompatibility, but 50% of PVP hydrogels are biocompatible (Lopes and 
Felisberti, 2003; Risbud et al. 2000). Furthermore, PVP can be coated on the 
polyurethane surface and firmly attach to the surface (Francois et al. 1996). This 
property is essential for this project. 
The goal of this study was to develop a novel hydrogel copolymer with 
HEMA, DHPMA, VP and EGDMA which was facile to coat on the glucose sensors, 
did not deter the detection of glucose and exhibits improved biocompatibility. In order 
to optimize the compositions of hydrogels swelling, SEM and water structure of 
hydrogels were characterized. Different formulations hydrogels were coated on the 
implantable glucose sensors by UV curing. Glucose sensors used for this study were 
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based on the long term excess enzyme loading coil-type implantable amperometric 
sensors (Yu et al. 2005;Yu et al. 2006). In vitro and in vivo evaluations of the 
hydrogel coated glucose sensors with and without PU were also undertaken. 
 
2.2 Experimental Procedures 
2.2.1 Materials. 
2-Hydroxyethyl methacrylate (HEMA) and 2, 3-dihydroxypropyl methacrylate 
(DHPMA) were donated by Benz R & D (Sarasota, FL，USA). They were used as 
received without further purification. N-Vinyl-2-Pyrrolidinone (VP) (99.9+%) was 
purchased from Sigma-Aldrich Co.( St. Louis, MO, USA) and purified by vacuum 
distillation to obtain a colorless liquid according to reference(Jansen et al. 2005). 
Ethylene glycol dimethacrylate (EGDMA), glucose oxidase (GOX) (EC 1.1.3.4, Type 
X-S, Aspergillus Niger, 157,500U/g), benzoic acid, gentamicin, ATACS5104 epoxy 
adhesive, Fluka Selectophore
® 
81367 polyurethane (PU) and tetrahydrofunan (THF) 
were obtained from Sigma -Aldrich Co.(St.Louis, MO, USA). 
1-phenyl-2-hydroxy-2-methyl-propan-1-one (Benacure 1173) from Mayzon 
Corporation (Rochester, NY, USA) was used as received. Dextrose (D-glucose), 
bovine serum albumin (BSA), and glutaraldehyde (50%) were obtained from Fisher 
Scientific (Pittsburgh, PA).  0.125 mm Teflon-covered platinum-iridium (9:1 in 
weight) and silver wires were obtained from World Precision Instruments, Inc. 
(Sarasota, FL，USA). High temperature mini round glue sticks were supplied by 
Adhesive Tech (Hampton, NH, USA). Hematoxylin and eosin were obtained from 
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Fisher Scientific (Pittsburgh, PA) and trichrome stains were purchased from 
Newcomer Supply (Middleton, WI). 
2.2.2. Synthesis of Poly (HEMA-DHPMA-VP-EGDMA) Hydrogel Series 
Various molar ratios of HEMA and DHPMA were weighed and mixed in 20 
ml glass vials. 9 mol % of VP, 1 mole% EGDMA and 1.5 mol% initiator Benacure 
1173 were added to the solutions (Table 2.1).  The solutions were diluted 1:1 with 
distilled water. After deoxygenation with argon gas, the solutions were injected into 
hand made glass cells measuring 55mm25mm1mm. The sides of the cells were 
secured with a glue gun.  The solution filled cells were placed under a UV lamp 
(Spectronics Corporation, Westbury, NY, USA) at a wavelength of 254nm for 100min. 
Argon gas was used to purge the system in order to minimize oxygen inhibition of the 
reaction.  Transparent uniform sheets were obtained and these xerogels were swollen 
in distilled water to yield hydrogels.  The water was refreshed every day for one 
week to remove any unreacted monomers.  
The hydrogels were freeze-dried for various studies using a Virtis 
Freezemobile 12XL freeze dryer (The Virtis Company Inc, Gardiner, NY, USA) to 
keep the pores inner morphology. 
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Table 2.1 Feed compositions of synthesized xerogels 
Mole% HEMA DHPMA VP EGDMA 
DHPMA0 90 0 9 1 
DHPMA20 70 20 9 1 
DHPMA40 50 40 9 1 
DHPMA60 30 60 9 1 
DHPMA80 10 80 9 1 
DHPMA90 0 90 9 1 
 
2.2.3 Scanning Electron Microscopy (SEM) 
The hydrogel samples obtained by the above method were cut and freeze-dried 
to determine the inner morphology.  The morphology of the freeze-dried gels were 
studied via a Hitachi Scanning Electron Microscope S-800 (Hitachi High 
Technologies, Pleasanton, CA) with 20nm gold coating by a HummerX sputter coater 
(Anatech, Ltd, Springfield, VA).  The working distance between the sample and 
electron (WD) was 5mm with 25.0 kV. 
2.2.4 Sorption Experiments 
Hydrogel samples were cut with a 12mm diameter cork bore to obtain uniform 
shapes.  All sheets were freeze-dried for one day and stored in a desiccator at room 
temperature.  The sorption behavior of hydrogels was monitored by detecting the 
increase in mass of the samples at different time intervals by Sartorius BP211D 
balance (  0.01mg, Sartorius Corporation, Edgewood,NY, USA).  In a typical 
sorption experiment, a pre-weighed dry gel sheet was immersed into water at 24±1℃ 
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in a Fisher Scientific Isotemp water bath (Pittsburgh, PA).  At a prescribed time 
intervals the hydrogel was taken out of solution and weighed after wiping off the 
excess water from the surface with Kimwipe paper (Kimberly-Clark Professional). 
The sorption degree, SD, of hydrogels was defined as follows: 
SD%=
d
dt
W
WW 
100= 100
d
t
W
M
                          (2-1) 
Where dW is the weight of the dry gel, tW is the weight of wet hydrogel at each 
time interval, and tM  is the gain in the weight of the dry gel at time t. 
The equilibrium water content (EWC) of the hydrogel was determined using the 
following equation: 
EWC%=

 
W
WW d 100= 100


W
M
                         (2-2) 
where W and M are the weight and weight gain of the swollen hydrogel at 
equilibrium separately. 
2.2.5 Differential Scanning Calorimetry (DSC) 
All calorimetric data were obtained via a TA Instruments 2920 differential 
scanning calorimeter (DSC, TA Instruments, New Castle, Delaware).  Nitrogen gas 
was passed through the instrument at a flow rate of 70ml/min. Before measurement 
the DSC was calibrated from -100℃ to 250℃ at a heating rate of 5℃/min with an 
indium standard. All the sample masses for DSC ranged from 4mg to 10mg. 
For the determination of glass transition temperature, samples were 
freeze-dried for one day and kept in a desiccator.  The samples were quickly 
weighed, sealed in aluminum pans, and immediately scanned from 30℃to 200℃. 
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Samples were cooled and rescanned; the glass transition was determined from the 
second heating cycle in order to minimize any aging effects.  The reported glass 
transition temperature was determined as midpoint at half heat flow or heat capacity.  
To measure the water structure of equilibrium swollen hydrogels, first samples 
were cut and weighed accurately after wiping off the surface water with Kimwipe 
paper and immediately sealed in Al pans. The DSC curves were measured heating 
from -100℃ to 20℃ with a heating rate 5℃/min.  Endotherm areas were 
determined.  
2.2.6 Sensor Preparation 
Hydrogel-coated glucose sensors used for this study were based on the 
coil-type implantable sensor previously described (Yu et al. 2005; Yu et al. 2006).  
The detail fabrication method of Pt/GOx and Pt/GOx/Epoxy-polyurethane base 
sensors can be found in those papers.  The coating process was achieved by applying 
a ~ 0.4 µL of 50% hydrogel solution to either the enzyme layer or the 
epoxy-polyurethane layer, using a 10 µL micropipette, and then curing under an argon 
atmosphere and a 254 nm UV light for 100 min.  Membrane surfaces were observed 
and photographed using an Olympus BX41 microscope (Quantitative Imaging Co., 
Canada).  The cured hydrogel coating was transparent and firmly attached to the 
sensor as shown in Figure 2.1. 
2.2.7 In vitro Evaluation Method 
Electrochemical measurements were performed with Apollo 4000 4-Channel 
Potentiostats (World Precision Instruments, Inc., Sarasota, FL).  Newly prepared 
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glucose biosensors were conditioned in a 5mM glucose /PBS (NaCl 8.76g, KH2PO4 
3.53g, Na2HPO4 3.40g, Benzoic acid 2g, water 10000ml) (ionic strength = ~ 0.16M) 
for at least 2 hours and then continuously polarized at +0.7V vs. Ag/AgCl until a 
stable background current was reached.  The response was determined as the time 
needed for the sensor’s current to reach 90% of (T90%, min) the maximum current 
when the glucose concentration changed from 5 mM to 15 mM.  The sensitivity (S) 
was determined using a two-point method and can be calculated by 
S (nA/mM) = 
10
515 mMmM II                       (3) 
where I15 mM and I5 mM represent the sensor response currents obtained in 15 mM 
and 5 mM glucose solutions, respectively. The sensors for long-term observation were 
stored in PBS. Calibration plots were obtained by stepwise adding 100 mM glucose 
solutions to 8.0 mL PBS. All measurements were performed at 241C. 
2.2.8 In vivo Biocompatibility Studies 
The epoxy-PU coated Silastic tubing (Dow Corning, Midland, MI) ( = ~ 4 
mm, length = ~ 50 mm), a DHPMA 80 bar ( = ~5 mm, length = ~50 mm), an 
epoxy-PU coated glucose sensor and a DHPMA 80 coated glucose sensor were 
implanted subcutaneously in rats for 28 days.  The tissues surrounding the implants 
were removed at day 28 and processed for histology with hematoxylin, eosin and 
trichrome stains (Galeska et al. 2001). 
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Figure 2.1 Sensor photos show thin layers of hydrogel coating: A. hydrogel on 
Pt/GOx sensor B. hydrogel on Pt/GOx sensor after swelling C. hydrogel on 
Pt/GOx/Epoxy-polyurethane base sensors D. hydrogel on 
Pt/GOx/Epoxy-polyurethane sensors after swelling 
 
 
 
 
 
 
 
 
1 mm 
A B 
C 
D 
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2.3 Results and Discussion 
2.3.1 Preparation of Hydrogels Sheets and Coatings 
A type I photoinitiator, Benacure 1173, undergoes unimolecular bond cleavage 
upon irradiation in argon atmosphere.  It produced well cured samples, including the 
thin layers used on the sensors (Lewis et al. 1975; Maillard et al. 1983).  The water 
present in the polymerization mixture minimized the heat of polymerization and 
bubble-free samples were obtained. The amount of solvent in the reaction mixture did 
not exceed the critical solvent concentration which would result in heterogenous 
samples (Peppas, 1986).  In order to avoid producing bubbles and obtain the 
homogenous transparent hydrogel, monomers were dissolved in water with the weight 
ratio around 1:1.  Even if there was a little heat produced, it would diffuse readily, 
and would not yield big bubbles inside the hydrogel.  In this work, homogenous 
hydrogel sheets and coatings of implantable glucose sensor were obtained by UV 
cured. 
2.3.2 Inner Sample Morphology 
The scanning electron micrographs shown in Figure 2.2 depict the dramatic 
effect of DHPMA on morphology.  The sample with no DHPMA exhibits irregular 
pores.   At 20% DHPMA the number and regularity of the pores increase.  This 
trend increases up to 80% DHPMA. At 90% DHPMA the structure is less regular, 
possibly due to the high swelling stresses which can induce tearing in the sample. 
Coatings for implantable glucose sensors must effectively transport water, glucose  
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Figure 2.2 SEM micrographs of inner gels (350 magnification): D0,D20, D40, D60, 
D80 and D90 
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and oxygen. From the morphology of different gels it can be seen that 80% DHPMA 
gives the most uniform, porous structure and therefore, might be an optimum 
candidate for permeable sensor coatings. 
 
2.3.3 Sorption Behavior 
The sorption versus time profile is shown in figure 2.3.  Both the equilibrium 
water content and the sorption rate increase with DHPMA content.  This is due to the 
extra hydroxy group in DHPMA which increases the hydrophilicity.  It has also been 
shown that increasing DHPMA content can slow the dehydration rate and increase the 
rehydration rate of the sample (Gates et al. 2003; Pescosolido et al. 1990).  This is 
ideal for the implantable glucose sensors, since dehydration reduces biocompatibility 
(McConville and Pope, 2001).  It has been stated that glucose sensor coatings should 
exhibit the equilibrium sorption degrees of over 120%, and, preferably over 200% 
(Van Antwerp et al. 1998).  Figure 2.3 demonstrates that the 80% DHPMA, again, is 
an optimum formulation for sensors.  
The water diffusion coefficient can be easily calculated when diffusion 
controls the transport process.  It is well known that sorption behavior in polymers is 
quite complex (Harmon et la. 1988;Harmon et al. 1987).  At one extreme, Fickian 
diffusion controls kinetics.  However, since swelling involves segmental relaxation, 
the relaxation rate can influence transport.  If the relaxation rate is slower than the 
diffusion rate, relaxation can dominate transport kinetics.  In reality, sorption 
behavior can range from pure Fickian behavior to pure relaxation behavior.  In pure 
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Fickian behavior, sorption versus the square root of time curves are linear up until 
about 60% of the equilibrium water content is imbibed (
M
M t ≤0.6). When relaxation 
dominates transport, sorption is linear with respect to time. The extent of influence 
from Fickian diffusion and relaxation is characterized by the time exponent in the 
following equation
 
(Franson and Peppas, 1983; Alfrey et al. 1966): 
  
M
M t  = Kt
n
 (2-4) 
Where, t is time, k is a constant and n is the time exponent. The time exponent, n, 
varies from 0.5 for pure Fickian control to 1 for pure relaxation control.  Table 2.2 
and Figure 2.4 show that transport kinetics are controlled by diffusion in these 
hydrogel systems, since n is close to 0.5(Wang and Wu, 2005).  
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Figure 2.3 The swelling degree as a function of time for the different DHPMA 
fraction hydrogels  
 
 
Figure 2.4 log
M
M t  versus logTime for the different DHPMA fraction hydrogels 
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Table 2.2 Dynamic Swelling Parameters 
Sample n 
M
M t  R
2
 D(cm
2
S
-1
)*10
5
 
DHPMA0 0.57 0.072-0.569 0.993 0.5 
DHPMA20 0.52 0.094-0.557 0.994 1.6 
DHPMA40 0.47 0.111-0.554 0.996 2.0 
DHPMA60 0.45 0.135-0.532 0.993 2.4 
DHPMA80 0.41 0.263-0.589 0.991 3.9 
DHPMA90 0.32 0.343-0.568 0.994 4.5 
 
All sample shapes are similar and the ratio of thickness (L) to diameter (Di) 
is about 1:10.  It is assumed that water diffuses into a planar sheet at a constant rate. 
When 
M
M t ≤0.5 the relationship between 
M
M t and time will fit equation 5 (Crank， 
1978).
 
M
M t = 
L
4
(

Dt
)
 0.5
                                          (2-5) 
The diffusion coefficient (D) values are estimated according to equation (5) and 
shown in Table 2.2.  From Table 2.2 it can be seen that (D) increases with DHPMA 
content.  All the swelling kinetics data show that when DHPMA content is increased 
the swelling ratio and water diffusion rate increased.  Since water acts as the 
diffusion medium between body fluid and the glucose sensor the faster the water 
transport characteristics of the hydrogel coating the better the detection of the glucose 
concentration.  
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2.3.4 DSC Results 
Table 2.3 shows that the Tgs of different xerogels composition do vary with 
DHPMA content.  This trend was noted this effect in an earlier study (Gates et al. 
2003).  The dihydroxypropyl side chain in DHPMA imparts greater free volume, 
which can facilitate the mobility and decrease the Tg.  However, this effect is offset 
by the extra hydroxyl group which forms hydrogen bonds in the network structures 
and restricts mobility  
 
Table 2.3 Tgs of different composition gels 
DHPMA% Tg(℃)(H) 
(1) 0 118 
(2) 20 119 
(3) 40 120 
(4) 60 117 
(5) 80 117 
(6) 90 120 
 
It is well known that the biocompatibility of hydrogels not only depends on the 
equilibrium water content but also on the state of water in the hydrogels
 
(Kim et 
al.,1980;Mirejovsky et al. 1991;GOxa et al. 2006;Jhon and Andrade, 2004).  Some 
techniques employed to study water structure in hydrogels are NMR (Chowdhury et al. 
2004; Capitani et al. 2001), dilatometry and electrical conductivity (Lee et al. 1975; 
Choi et al. 1977), dielectric relaxation spectroscopy (Kyritsis et al. 1995), 
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dynamic-mechanical spectroscopy (Lustig et al. 1991) and differential scanning 
calorimetry (Murphy et al. 1988; Pedley and Tighe, 1979).  The classification of 
water in the hydrogels depends on the techniques used.  According to the most 
common method, DSC, water in the hydrogel is classified as freezing free water, 
freezing bound water and non-freezing water.  Free water does not take part in 
hydrogen bonding with polymer molecules.  It has a similar transition temperature, 
enthalpy and DSC curves as pure water (Nakamura et al. 1983).  Freezing bound 
water interacts weakly with polymer molecules and has a phase transition temperature 
lower than 273K.  Non-freezing bound water is complexed with the polymer chain 
through hydrogen bounds and has no detectable phase transition over the temperature 
range from 200K to 273K (Higuchi et al. 1984).  Since the freezing water effects 
transport and biocompatibility of the hydrogels (Mirejovsky et al. 1991; Goda et al. 
2006). it is important to detect water structure inside hydrogel for optimization of 
material properties in biomedical applications. 
 
Table 2.4 Water structures of different composition hydrogels 
 
Sample EWC% Wf% Wnf% Wf/Wnf Wf/EWC% 
D0 48.8 21.6 27.2 0.79 44.3 
D20 52.0 30.0 22.0 1.36 57.7 
D40 60.1 39.9 20.2 1.98 66.4 
D60 65.5 50.7 14.8 3.43 77.4 
D80 69.4 56.2 13.2 4.26 81.0 
D90 69.9 41.2 28.7 1.44 41.1 
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In this work the water structure in equilibrium-swollen hydrogel was studied 
by DSC.  Since the peak shape and the maximum peak temperature of heating and 
cooling process are dependent on the heating rate (Higuchi and Iijima,1985; Chan et 
al. 1992) and different heating and cooling cycles can cause the evaporation of water 
from the hydrogel and condensation inside the sample pan(Roorda et al. 1988),
 
only 
the results of the first heating runs were used to calculate relative content of freezing 
water (Wf%) and the relative content of non-freezing water (Wnf%). The Wf% was 
calculated by the melting enthalpy of the hydrogel divided by the melting enthalpy of 
pure water.  The observed melting enthalpy is calculated by the area under the 
endothermic curve.  The melting enthalpy of bulk water is taken as 333.3J/g (Ahmad 
et al. 1994 ).  Wf% and Wnf% are calculated by the following equation:  
Wf%=Wfree%+Wf-bond%=
wH
H


100    (2-6) 
Wnf%=EWC-Wf% 
3.333 wH J/g 
H is the observed melting enthalpy.  wH  is the melting enthalpy of bulk water. 
The relative content of non-freezing water is obtained by the difference between the 
equilibrium water content, EWC, and the relative content of freezing water. The EWC, 
Wf% and Wnf% are listed in Table 2.4. Figure2.5 shows the DSC curves obtained 
during heating run from -100 ℃ to 20℃. 
From Table 2.4 we can see that when the DHPMA content was increased from 
0 to 80% the content of freezing water increased and non-freezing water decreased. 
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The ratio of freezing water to non-freezing water reached a peak at D80.  The 
freezing water increase may be due to greater free volume because of the 
dihydroxypropyl side chain while the non-freezing water decrease may be due to 
more hydrogen bonds formed between the side chains, which results in less hydrogen 
bond formed between water and hydroxyl groups.  According to reference (Liu et al. 
2000), hydrogel porosity increased with NaCl concentration in the swelling medium. 
This leads to an increase in freezing water content and a decrease in non-freezing 
water content and was thought to stem from the increase in porosity, as seen in SEM 
pictures, and DHPMA content. However, hydrogels without HEMA showed a 
decrease in freezing water and increase in non-freezing water. From the results it can 
be seen that 80% DHPMA shows the highest freezing water content.  Since the 
content of freezing water determines the transport properties of the hydrogel 
(Mirejovsky et al. 1991), it can be expected that 80% DHPMA is the best for transport 
of water, glucose and oxygen to the biosensor according to
 
reference(Goda et al. 2006) 
higher freezing water content also results in less protein deposition on the polymer 
surface.  Future studies will characterize the effect of swelling and water structure on 
mechanical relaxations.  Previous publications documented the fact that hydrophilic 
groups on the polymer backbone influence secondary relaxations and swelling 
responses(Gates et al. 2003).  
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Figure 2.5 DSC heating curves of hydrogels with different DHPMA content, 
performed at the heating rate of 5.0℃min-1 
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2.3.5 Sensor Performance of Hydrogel-Coated Glucose Sensors 
Hydrogels of various compositions were used for coating glucose sensors and 
the characteristics of the corresponding sensors were examined in vitro.  Table 5 
gives the measured results of sensitivity (S, nA/mM) and response time (T90%, min) at 
Day 7 and Day 28.  For different compositions of hydrogels a higher percentage of 
DHPMA resulted in the higher sensitivity and shorter response time in accordance 
with the results of SEM morphology, swelling behavior and water structure 
observations.  
Among five hydrogels, D0 showed the best long-term stability but its response 
was too slow. D20 to D60 failed to gave a stable sensor response at day 28. 
Comparatively, the sensor with a D80 coating showed the best performance. At day 
28, the sensor response curve with stepwise glucose increases was still good (Figure 
2.6) despite a 40% loss of the sensitivity at day 28.  
 
Table 2.5 Response sensitivities (S) and times (T90%) of various hydrogel (HG)-based 
glucose sensors (mean SD) 
Pt-Ir/GOx/HG (n=4) D0 D20 D40 D60 D80 
Day 7 
S (nA/mM) 6.1±2.6 6.3±2.2 10.5±1.7 16.2±0.8 18.4±2.1 
T90% (min) 12.7±2.2 10.5±2.0 8.6±1.2 6.9±1.3 4.6±1.0 
Day 28 
S (nA/mM) 3.9±0.4 
Low response 
10.9±2.1 
T90% (min) 3.5±1.5 4.3±1.2 
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Figure 2.6 Representative response curves of a Pt-Ir/GOx/HG-D80 glucose sensor at 
day 7 and 28, respectively. 
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Table 2.6 Response characteristics of various hydrogel-EPU-based glucose sensors* 
(mean SD) 
Pt-Ir/GOx/EPU/HG 
(n=4) 
Control D0 D20 D40 D60 D80 
Day 7 
S (nA/mM) 3.3±1.1 0.6±0.4 0.6±0.4 1.2±0.8 3.0±1.4 3.2±0.8 
T90% (min) 2.9±1.0 27.0±3.4 24.3±2.7 18.4±7.4 17.4±2.2 9.1±1.4 
*S: response sensitivity of sensor; T90% (min): the time to reach 90% of the maximum 
response when glucose varies from 5 mM to 15 mM;  
 
 
Figure 2.7 Calibration plots from a Pt-Ir/GOx/HG-D80 sensor and a 
Pt-Ir/GOx/HG-D80 sensor. Sampling time was between 4 to 5 min after each stepwise 
addition of a concentrated glucose solution. 
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Figure 2.7 shows the calibration lines of a Pt-Ir/GOx/HG-D80 sensor and a 
Pt-Ir/GOx/HG-D80 sensor.  The linear range of Pt-Ir/GOx/HG sensors was in the 
range of 1 to 15 mM.  It was thought that the poor linearity at high concentration 
could be significantly improved by adding an epoxy-polyurethane membrane in 
between the enzyme layer and the hydrogel coating. Such a sensor, i.e. 
Pt-Ir/GOx/EPU/HG, extended the linear range to 40 mM (see Figure6).  Table 2.6 
summarized the sensitivity and response time of various Pt-Ir/GOx/EPU/HG sensors. 
Since the permeability of the epoxy-polyurethane membrane is much lower than that 
of the hydrogel coating layer, the epoxy-polyurethane membrane played the major 
role in limiting diffusion.  Therefore, when the hydrogel was more permeable, the 
sensitivity was closer to that of the control sensors (i.e. Pt-Ir/GOx/EPU).  However, 
the additional hydrogel layer caused a significant response delay, especially for D0, 
D20, D40 and D60. D80 was determined to meet the design requirement of 
implantable glucose sensors.  
2.3.6 In vivo Biocompatibility 
PU coated Silastic tube ( = ~ 4 mm, length = ~ 50 mm), 80% DHPMA 
hydrogel bar ( = ~ 4 mm, length = ~ 50 mm), PU coated glucose sensor and 80% 
DHPMA hydrogel coated glucose sensor were implanted subcutaneously in rats for 28 
days.  Figure2.8 shows the histology results of the PU coated Silastic tube (A), 
hydrogel bar (B), PU coated glucose sensor (C) and hydrogel coated glucose sensor 
(D). It can be seen that about 200 µm and more than 500µm in thickness fibrous 
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capsule formed around the silastic tubing and PU coated glucose sensor with obvious 
inflammation of the cells.  While only 30~ 60 µm in thickness, the fibrous capsule 
formed at the hydrogel bar and hydrogel coated sensor, respectively.  80% DHPMA 
hydrogel can reduce the fibrosis and inflammation and it should make the lifetime of 
glucose sensor longer.  A sensor with a hydrogel coating would not only have all 
advantages of an epoxy-polyurethane glucose sensor (e.g. long-term stable, wide 
response range) but also minimize the tissue reactions occurring around the implanted 
sensor.  This study was limited to 28 days.  There is no reason to expect that the 
biocompatibility of this material would change after this period.  As previously 
stated in the introduction, the main innovation of this hydrogel compared to similar 
materials is the increase in mechanical strength which makes it suitable to coat 
biosensors for long term implantation.  
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Figure 2.8. Histology slides: (A) epoxy-polyurethane-coated silastic tubing ( = ~ 4 
mm, length = ~ 50 mm), (B) one hydrogel bar ( = ~ 4 mm, length = ~ 50 mm), (C) 
one PU coated sensor (D) one hydrogel coated sensor (rat 4, left) implanted 
subcutaneously in rats for 28 days. 
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2.4 Conclusion 
In this study different hydrogels with various DHPMA content were 
successfully synthesized and coated on to glucose sensors by UV polymerization. The 
higher freezable water content, swelling rate and uniform porosity that result from 
high DHPMA content increase the sensitivity and shorten the response time of the 
glucose sensors. The linear range of a glucose sensor only coated with hydrogel is 
short. However, it can be improved by coating the epoxy-PU with a layer of hydrogel 
because PU can control the diffusion of glucose molecules. Since the hydrogel 
minimizes the fibrosis and inflammation, it shows promise for use in implantable 
glucose sensors. 
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CHAPTER 3  
USE OF HYDROGEL COATING TO IMPROVE THE PERFORMANCE OF 
IMPLANTED GLUCOSE SENSORS 
Foreword:8 D80 coated Pt/GOx/epoxy-polyurethane glucose sensors were implanted 
into 4 rats (2 sensors/rat).  The original attempt of in vivo implanted glucose sensors 
was not successful, because only 25% of the sensors were working at 4 weeks.  In 
order to further improve the efficiency of implanted glucose sensors, another series of 
novel hydrogels were developed based on copolymer of HEMA and DHPMA. 
3.1. Introduction 
The material–tissue interaction during sensor implantation, i.e. so-called 
biofouling which may include protein/platelet deposition, or the attachment of 
inflammatory response-related cells, is one of the major causes in unpredictable and 
unexplainable behaviors of implanted glucose biosensors.  The performance of 
implanted biosensors can greatly benefit from the use of more biocompatible outer 
most coatings such as hydrophilic alginate (Shichiri et al., 1989), phosphorylcholine- 
modified polyurethane (Yang et al.,2000), 2-methacryloyloxyethyl phosphorylcholine 
-co-n-butyl methacrylate (Nishida et al., 1995; Yasuzawa et al., 2000) and hydrogels 
(Suri et al., 2003).  Hemocompatible synthetic copolymers containing phosphorylch- 
oline significantly improved the performance of the sensors both ex vivo in whole 
blood and in vivo.  Unfortunately, these polymers are mechanically weak and can be 
easily dislodged in flowing blood or in the subcutaneous tissue and are thereby are not 
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useful for long-term application.  Hydrogels are a kind of network polymer 
possessing a degree of flexibility very similar to natural tissue due to their significant 
water content.  When in physiological solutions, hydrogels can reduce protein 
adsorption and the subsequent inflammatory response.  In the medical field, 
hydrogels have been extensively used as scaffolds in tissue engineering and sustained 
release drug delivery systems (Norton et al., 2005).  The properties of some 
hydrogels make them attractive candidates for use in glucose sensors. A glucose 
sensitive phenylboronic acid-based hydrogel used pressure stimuli to detect glucose 
(Lei et al., 2006).  Similarly, a polyacrylamide hydrogel-coated cantilever sensor 
was constructed and responded to swelling which directly correlated with glucose 
concentration (Ji et al., 2005).  Glucose oxidase was immobilized in polyacrylamide 
gels via crosslinking.  Swelling and viscoelastic properties were used along with 
amperometric measurements to evaluate the materials for use in biosensors 
(Fernandez and Lopez, 2005).  Phenylboronic acid containing hydrogels were shown 
to exhibit red shifts in holograms which quantify glucose concentrations (Kabilan et 
al., 2005).  Another group of researchers used photonic properties of boronic acid 
based hydrogels to sense glucose(Alexeev et al., 2004). Berner et al. (1998) 
determined that the iontophoretic properties of hydrogels can be used to monitor 
glucose.  Certain hydrogels can be doped with glucose-reactive fluorescent dyes and 
the light that is emitted changes with glucose concentration (Thoniyot et al., 2006). 
Hydrogels can potentially be used as the outermost coating of implanted 
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glucose sensors to reduce foreign body reaction surrounding the sensor, thereby 
improving the in vivo sensor performance. Polyethylene oxide-based hydrogels were 
used as diffusion-limiting membranes in glucose sensors and short-term studies were 
implemented by subcutaneously implanting hydrogel-coated glucose sensors in 
Sprague–Dawley rats (Quinn et al., 1997, 1995). Most hydrogels like pHEMA are too 
weak to maintain their membrane structure and function during implantation, 
therefore, long-term studies are difficult. 
Hydrogels include neutral hydrogels, ionic hydrogels and swollen 
interpenetrating polymeric networks. However, neutral hydrogels can better meet the 
sensor coating requirements of biocompatibility and structural stability. A neutral 
hydrogel, PHEMA and DHPMA (Wichterle and Lim, 1960),was previously 
developed for contact lenses. This gel was shown to exhibit an increased resistance to 
dehydration (Gates et al., 2003). The copolymer exhibited high equilibrium water 
content and good mechanical properties. These copolymers have great potential for 
producing more durable coatings for glucose sensors.  
In this study, novel HEMA-DHPMA-based hydrogels were developed and 
used to improve the biocompatibility of implantable glucose biosensors. The porosity 
and water content of the copolymer were improved by the addition of a structural 
strengthener, N-vinyl-2-pyrrolidinone (VP; McConville and Pope, 2001). The 
compositions of monomer mixtures were optimized and the resulting hydrogels were 
characterized. A selected hydrogel was used for coating an implantable glucose sensor 
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(Yu et al., 2006). The in vitro and in vivo sensor performance of hydrogel-coated 
sensors were examined and discussed. 
3.2 Experimental  
3.2.1. Chemicals and Materials  
Monomers HEMA and DHPMA were donated by Benz R & D (Sarasota, FL). 
Other chemicals including VP, EGDMA and Benacure 1173 were obtained from 
Sigma–Aldrich (St. Louis, MO).  VP was purified by vacuum distillation prior to 
polymerization according to reference (Jansen et al. 2005).  0.020 inch Silastic 
tubing (i.d.×o.d. = 0.51mm×0.94 mm) was purchased from Dow Corning (Midland, 
MI).  Size 3–0 Prolene (polypropylene) were obtained from Ethicon (Somerville, 
NJ).  I.V. catheters (14 ga.) with a needle were obtained from Terumo Medical 
Corporation (Somerset, NJ).  Sprague–Dawley outbred rats (male, 375–399 g) were 
purchased from Harlan (Dublin, VA).  VetBondTM glue came from 3M (St. Paul, 
MN). 
3.2.2. Photopolymerization of Poly(HEMA-DHPMA-VP-EGDMA) Hydrogels 
Pure monomers (all liquid state) were first combined to prepare the following 
four formulations (termed VP0, VP15, VP30 and VP45) listed in Table 3.1.  The 
mixtures were diluted 1:1 with deionized water, 1% (w/w) Photoinitiator (Benacure 
1173) was added, and the solutions mixed at room temperature.  Polymerization was 
performed as follows.  After purging each solution with argon for 2 min, each 
solution was transferred into a glass mold (L×W×H=55mm×25mm×1 mm).  The 
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molds were placed under a 254 nm UV light for 100–110 min in an argon atmosphere 
at 25 
◦
C to polymerize the hydrogels.  The hydrogels were removed from the molds 
and placed into 500 ml of deionized water at 25 
◦
C.  The water was changed daily for 
one week to remove soluble residues.  
 
Table3.1 Feed composition of synthesized hydrogel 
Molar ratio VP 1HEMA:1DHPMA EGDMA 
VP0 0 99 1 
VP15 15 84 1 
VP30 30 69 1 
VP45 45 54 1 
For formation of the hydrogel coating on the glucose sensor tip, 0.4, 0.8 or 1.2 
μl of the argon-purged VP30 solution (including additional water and photo-initiator) 
was pipetted onto the sensor tip.  The solution was allowed to spread evenly over the 
surface of the tip (bare or EPU-coated).  After exposing to UV light under argon (as 
above), the sensors were stored in phosphate buffered saline until further use.  
3.2.3. Analysis of Hydrogels 
The purified hydrogel samples were cut and freeze-dried for 24 h, and then 
stored in dessicator at room temperature.  The inner morphology of cutting section 
was examined using an S-800 Hitachi Scanning Electron Microscopy System (Hitachi 
High Technologies, Pleasanton, CA). 
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The glass transition temperature (Tg) was measured using a model 2920 
differential scanning calorimeter (DSC, TA Instruments, New Castle, DE) under a 
pressurized nitrogen atmosphere to avoid sample degradation.  In this process, a 
4–10mg freeze-dried sample was sealed in aluminum pans.  The samples were 
scanned from 30 to 200 ◦C at 5◦C per min.  Each sample was tested at least twice. 
Fourier transform infrared spectroscopy (FT-IR) was carried out on the 
rectangular samples that were dessicated at room temperature after freeze-dried, using 
a Nicolet Avatar 320 FT-IR Spectrophotometer (Nicolet, Madison, WI) with a 64 scan 
per sample cycle at a resolution of 4 cm−1.   
For the determination of equilibrium water fraction (EWF), hydrogel samples 
were lyophilized to obtain dry mass (Md).  Xerogels were then swollen in a pH 7.4 
phosphate buffer solution (PBS, ionic strength =~0.16 M) at 37 
◦
C for 2 days. The 
swollen hydrogels were pat-dried with filter paper and weighed every 2 h until the 
weight reached a constant value (Meq). The water Fraction (EWF) at swelling 
equilibrium was calculated by: 
EWF(%) = (Meq −Md) × 100/Md    (3-1) 
3.2.4. Sensor Preparation 
Glucose sensors were based on coil-type design (Yuet al., 2006)(Figure3.1). 
Briefly, the coil-type glucose biosensors were prepared by winding the top 10mm of a 
40–50mm long platinum wire (Φ0.125mm, including 10% iridium in weight) along a 
30-gauge needle to form a coil-like cylinder which was filled with cotton.  The 
enzyme layer was formed over the cylinder by coating an aqueous solution of 
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10mg/ml GOx, 30–40mg/ml BSA and 0.6% (v/v) glutaraldehyde.  In this study, the 
novel membrane configurations were used on Pt/GOx or Pt/GOx/EPU sensors.  The 
outermost hydrogel coating was formed by applying a 0.4–1.2μl of 50% hydrogel 
solution to the Pt/GOx or Pt/GOx/EPU sensors as described above.  All sensors used 
in this study were visually inspected for defects under 40× magnification using a 
dissection microscope (Figure3.2) and then stored in PBS. 
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 Figure 3.1 Schematic diagram of hydrogel-coated sensing element of the glucose 
electrode. Figure adapted from Ju (Ju, 2006). 
(1) Teflon-covered Pt-Ir wire; 
(2) Ag/AgCl reference wire; 
(3) Collagen scaffold; 
(4) Electrically-insulating sealant; 
(5) Epoxy-Pu outer membrane; 
(6) Enzyme layer; 
(7) Stripped and coiled Pt-Ir wire; 
(8) Cotton fiber with GOX gel. 
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Figure 3.2 Photo of sensor coated with hydrogel (40× magnification using a dissection 
microscope) 
3.2.5. In vitro Sensor Evaluation 
The in vitro performance of the sensors was examined in glucose/PBS to 
determine the response time, sensitivity and linear range of sensors at different days. 
The response time represented the required time to reach 90% of the maximum 
response when the glucose concentration increased from 5 to 10mM.  The sensitivity 
of the Pt/GOx/hydrogel sensors was measured using 5 and 10mM glucose/PBS.  The 
linear range was obtained from a stepwise glucose increase from 2 to 30mM.  All 
test solutions were prepared using pH 7.4 PBS (ionic strength =~0.16M) and 
amperometric measurements were performed at room temperature at 0.7V vs. 
Ag/AgCl. 
3.2.6. Animals and Surgical Procedures 
The sensors were disinfected during polymerization of the hydrogel coating 
under a 254 nm UV light.  Sensors used for implantation were pre-conditioned in 
Ag/AgCl Electrode 
1 mm 
Sensing Element with 
Hydrogel Coating 
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sterile saline for 2 days.  The sensor immobilization method for implantation was 
according to paper (Long et al., 2005) and further improved. Briefly, the sensor wires 
were covered with a section of 0.02 in. silastic tubing (2 cm in length).  An overhand 
knot then was made in the middle of this section to use as a suturing site (i.e. for 
anchoring) during implantation and to prevent the sensor moving out of the skin.  
For each sensor placement (two/rat), a ~1.5 cm length longitudinal incision was made 
1.5 cm laterally to the dorsal midline, 3–4 cm caudally from the neck.  A 
subcutaneous pocket was created by using blunt surgical scissors before sensor wire 
placement.  A 14 ga. I.V. catheter was inserted through the subcutaneous tissue area 
to the incision from the low back.  The needle was withdrawn leaving the cannula in 
the subcutaneous tissue.  The sensor tip and wires were carefully fed into the cannula 
through the incision.  The sensor was secured to the skin by passing a 3–0 Prolene 
suture through the knot of the silastic tubing covered sensor wires and the incision 
was closed using 3–0 Prolene sutures.  After implantation, a ~4mm length of Silastic 
tubing containing a ~8mm length of sensor wires was allowed to protrude from the 
skin.  
All protocols were approved by the University of South Florida Institutional 
Animal Care and Use Committee (IACUC).  
3.2.7. In vivo Evaluation Method  
During the course of in vivo testing, a continuous flow anesthesia system was 
used to deliver 1.5% isofluorane to the rats with 1.0 l/min oxygen.  A maximum of 8 
sensors were continuously monitored for 2–3 h by using two Apollo 4000 
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potentiostats (4 channels each; World Precision Instruments, Sarasota, FL).  
Response currents (nA) were acquired at 1 s intervals every second and dynamic 
current (nA) vs. time (s) curves for all sensors were simultaneously displayed.  After 
a run-in period of approximately 1 h, a stable signal was obtained from the sensors. 
Dextrose (0.5–0.8 ml of a 50% (w/v) solution) was administered intraperitoneally 
using a 27 ga. needle.  Figure 3.3 shows the in vivo continuous glucose monitoring 
procedure.  Following the injection, a drop of blood was sampled every 6–8 min 
from the transected distal rat tail and blood glucose level was determined using a 
portable glucometer (FreeStyleTM; TheraSense, Alameda, CA).  The sensor 
sensitivity was calculated by dividing the current change by the blood glucose 
difference between the initial (before dextrose injection) and the peak status (after 
dextrose injection). 
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Figure 3.3 In vivo Continuous Glucose Monitoring Procedure. Figure adapted 
from Ju’s dissertation 
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3.3 Results and Discussion 
3.3.1. Characterization of Hydrogels 
After polymerization, hydrogels VP0, VP15, VP30 and VP45 were transparent 
and colorless in appearance and had a uniform and smooth surface, indicating that 
addition of VP did not result in phase separation or deterioration in the uniformity of 
the cured hydrogels.  FT-IR spectrometry (shown in Figure3.4) revealed specific 
carbonyl adsorption peaks at ∼1735 cm−1 (corresponding to polymerization of 
HEMA o rDHPMA) and∼1655 cm−1 (corresponding to polymerization of VP) 
(Yaung and Kwei, 1998).  As VP concentration was raised, the VP carbonyl peak 
increased. FTIR results indicate that VP was successfully co-polymerized with 
HEMA and DHMPA. 
The measured glass transition temperature values (Tg) of VP0, VP15, VP30 
and VP45 were 111.88, 121.72, 133.86 and 143.75
o
C, respectively (shown in 
Figure3.5).  Due to formation of hydrogen bonds between the carbonyl group in the 
PVP network and OH groups on the PHEMA or PDHPMA chains, VP effectively 
enhances the interactions between polymer chains and restricts the mobility of chains 
(Jin et al., 2006). Consequently, Tg values increased with increasing VP 
concentration. 
VP improved porosity of the hydrogels. Without VP, the copolymer of HEMA 
and DHPMA did not show pores in Figure 3.6 while the hydrogels with VP were 
highly porous.  The pore size increased when VP increased in the range of 0–45%. 
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According to higher magnification SEM photos (Figure3.7), it can be seen that nets 
start to appear inside the gel on the surface of the pores from VP15 and VP30.  There 
are more nets insede VP30 than VP15. When it is magnified to 10K times, it can be 
seen that some big pieces of structures combined with nets present on the surface of 
the pores.  The diameter of net string is about 50nm.  However, there are no nets on 
the surface of pores of VP45. 
Equilibrium water fraction EWF values for VP0, VP15, VP30 and VP45 were 
146%, 149%, 166% and 217% (wt%), respectively.  In consideration of 
biocompatibility, the hydrogel with a large EWF and large pores would be preferred.  
In order to detect the durability of these novel hydrogels, hydrogel samples (n 
= 4/hydrogel) were stored in water at room temperature for 4 weeks.  Fortunately, no 
significant weight loss was observed.  However, VP45 spontaneously broke into 
several smaller pieces.  From SEM pictures (Figure3.6 and 3.7) nets are present 
inside the gel on the surface of the pores of VP15 and VP30.  These nets may 
strengthen polymer matrix with high water content.  Since there are no nets on the 
surface of pores of VP45, VP45 was observed fragility probably due to swelling 
stresses as a result of the high water content.  Balancing the properties of water 
content, porosity and durability of various hydrogels, VP30 was selected for coating 
sensors for more in-depth in vitro/in vivo performance testing. 
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Figure 3.4 FTIR of four freeze-dried samples (the thickness of samples are 
around 0.5mm, taken by reflected light) 
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Figure 3.5 DSC of four freeze-dried samples 
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Figure 3.6 A SEM of sample VP0 
 
Figure 3.6 B SEM of sample VP15 
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Figure 3.6 C SEM of sample VP30 
 
Figure 3.6 D SEM of sample VP45 
Figure 3.6 Scanning electron microscopy images of four freeze-dried hydrogel 
samples (magnification: 350×, bar = 50μm). 
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Figure 3.7 A SEM of sample VP15(magnification ) 
 
Figure 3.7 B SEM of sample VP30(magnification ) 
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Figure 3.7 C SEM of sample VP30(magnification ) 
 
Figure 3.7 D SEM of sample VP30(magnification ) 
 
Figure 3.7 Scanning electron microscopy images of VP15 and VP30 
freeze-dried hydrogel samples with different magnification  
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3.3.2. In vitro Performance of Pt/GOx/VP30 Sensors 
In order to improve the long-term biocompatibility of the sensors in vivo, the 
hydrogel coating must be thick enough to be durable.  On the other hand, if the 
coating is too thick and/or relatively less porous, the sensor response will be very 
slow. The wet coating thickness was estimated by the volume of the coating solution 
(Vc).   Volumes of 0.4, 0.8 and 1.2 μl of VP30 solution on the enzyme layer of 
Pt/GOx sensors (n = 4).  In this case, the hydrogel layer served as the 
diffusion-limiting membrane.  Compared to the control sensors (Pt/GOx), the 
hydrogel layer did not improve the sensor response linearity; neither did it 
significantly reduce sensitivity except for the thicker coating (Table 3.2).  The 
calibration plots from Pt/GOx/VP30 sensors with coating layers formed from 0.4, 0.8 
and 1.2μl of VP30 solutions are shown in Figure 3.8.  The thicker coating did not 
improve linearity but reduced sensitivity.  After the sensors had been in water for 28 
days, all coatings were still firmly attached to the sensors but the sensitivity decreased 
~50%. 
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Table 3.2 Influences of Coating Thickness on Sensor Response 
 
Sensor 
 (n=4) 
VP30 
Coating 
Volume 
(µL) 
S 
(nA/mM) 
T90% 
(min.) 
Pt/GOx 0.0  48.2±6.3 0.22±0.07 
Pt/GOx/VP30 
0.4 47.6±2.8 1.1±0.1 
0.8 45.4±1.5 1.4±0.2 
1.2 34.7±1.8 1.9±0.3 
Pt/GOx/EPU 0.0 3.0±2.1 1.4±1.1 
Pt/GOx/EPU/VP30 
0.4 3.0±1.6 3.4±0.9 
0.8 2.9±2.2 6.4±3.0 
1.2 2.7±0.6 8.1±2.2 
 
 
Figure 3.8 Calibration plots for Pt/GOx and Pt/GOx/VP30 glucose sensors. 
Data are the means of measurements from 4 sensors at day 3. Error bars are ±standard 
error. 
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3.3.3 In vitro Performance of Pt/GOx/EPU/VP30 Sensors 
Due to the poor linearity, Pt/GOx/VP30 sensors might not be able to meet the 
basic requirement of in vivo measurements for accuracy and precision.  Though 
non-linear calibration can be performed in an effort to improve measurement 
reliability, a better solution is to add an additional diffusion-limiting membrane in 
between the hydrogel layer and the enzyme layer, for example, a low permeability 
epoxy-polyurethane membrane (Yu et al., 2006).  Such sensors with hydrogel 
coating, i.e. Pt/GOx/EPU/VP30, were prepared using similar methods as those used 
for preparing Pt/GOx/VP30 sensors and tested in glucose/PBS.  It was found that 
hydrogels could firmly attach to the epoxy-polyurethane membrane.  The sensitivity 
was decreased to about 10% of the sensitivity of Pt/GOx/VP30 sensors, which did not 
change with an increase in hydrogel coating (Table 3.2).  This was because the 
epoxy-polyurethane was much less permeable than the hydrogel and played the 
decisive diffusion-limiting role.  The linearity of the sensor’s response was 
significantly improved by the epoxy-polyurethane membrane and was at least in the 
range of 2–30mM.  The sensor response was dramatically delayed when the 
hydrogel coating was thicker (the response time is proportional to the square root of 
membrane thickness (Baronas et al., 2003).  For 0.4, 0.8 and 1.2 μl of hydrogel 
coating, the response time was 3.4±0.9, 6.4±3.0 and 8.1±2.2 min, respectively.  Thus, 
further experiments were carried out using the sensor with 0.4 μl of VP30 coating. 
The Pt/GOx/EPU/VP30 (0.4μl) sensors did not show a decline in either sensitivity or 
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linearity over 28 days (Figure 3.9).  The coating was still visible and firmly attached 
to the sensor after 28 days. 
3.3.4. In vivo Performance of Pt/GOX/EPU/VP30 Sensors 
Eight Pt/GOx/EPU/VP30 (0.4 μl) sensors were subcutaneously implanted in 
four rats (two sensors/rat) and the in vivo sensitivity of each sensor was tested at days 
7, 14, 21 and 28.  The testing results are summarized in Table 3.3.  All sensors kept 
functioning in the first 3 weeks and produced an in vivo response sensitivity of ~4 
nA/mM. At day 28 after implantation, 3 of 8 implanted sensors still performed.  It 
has been reported that 68 Pt/GOX/EPU sensors were tested in vivo and the sensor 
survival at day 21 was 13.5% (Long et al., 2005).  This suggests that the addition of 
hydrogel coating apparently improves the long-term performance of the implanted 
glucose sensors.  
The improvement might be attributable to the excellent biocompatibility of the 
hydrogel coating.  Representative histological sections, prepared from tissue 
surrounding a Pt/GOx/EPU/VP30 sensor and a Pt/GOx/EPU sensor at day 28 after 
implantation, are shown in Figure 3.10. Only a few inflammatory cells were observed 
in the tissue surrounding hydrogel-coated sensors (Figure 3.10B).  Without hydrogel 
coating, many inflammatory cells appeared (Figure 3.10A).  The thickness of the 
fibrous tissue around the Pt/GOx/EPU/VP30 sensor was 50–100μm, much less than 
the thickness of 100–500μm which was routinely observed in tissue surrounding 
Pt/GOx/EPU sensors (Long et al., 2005).  The reason for the functional failure of the 
other five sensors at day 28 in this study is unknown. Histological results did not 
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show any apparent differences between the tissue surrounding the surviving sensors 
and the tissue surrounding the failed sensors. 
 
 
 
Table 3.3 In vivo sensor sensitivity of Pt/GOx/EPU/VP30 sensors (n=8) 
 
Rat No. 1 2 3 4 Average ± 1 
Sensor left right left right left right left right Standard Error 
Day 7 12.0 5.5 2.6 2.1 4.6 1.2 2.6 1.4 4.0 ± 1.3 
Day 14 4.4 7.3 1.5 5.8 3.4 1.9 4.2 2.1 3.8 ± 0.7 
Day 21 6.6 4.2 1.5 5.6 5.3 2.1 2.0 5.4 4.1 ± 0.7 
Day 28 0 0 0 0.9 0 0 4.2 2.2 N/A 
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Figure 3.9 Calibration plots for Pt/GOx/EPU/VP30 (0.4ul) sensors at day 3, 7, 16 and 
28. Data are the means of measurements from 4 sensors. Error bars are ±standard 
error. 
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Figure 3.10 Hematoxylin and eosin-stained sections of tissue surrounding glucose 
sensors implanted subcutaneously in rats for 28 days. The photo (A) shows the 
capsular tissue formed around a Pt/GOx/EPU sensor. The photo (B) shows 
thecapsular tissue formed around a Pt/GOx/EPU/VP30 (0.4μl) sensor. 
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3.4. Conclusion 
This study has provided a feasible approach to design and select the properties 
of the copolymer for coating implantable biosensors. For the first time, animal 
experiments were used to demonstrate that a hydrogel coating was effective in 
minimizing tissue reactions surrounding implanted minimally invasive needle-type 
glucose biosensors. With a hydrogel outermost coating and an appropriate 
diffusion-limiting layer, significant improvements of the in vivo performance of 
implanted glucose sensors can be anticipated. 
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CHAPTER 4 
EFFECT OF NOVLE HYDROGEL COMPOSITION ON TARGETED 
DEXAMETHASONE-21 PHOSPHATE DISODIUM SALT DELIVERY  
 
4.1. Introduction 
When implants such as biosensors, pacemakers and bioartificial organs are 
implanted in the body, acute inflammation can occur within seconds or may be 
delayed for days.  Without suppressive agents, chronic inflammation and fibrosis 
usually follows.  The implants will lose normal functions with these tissue reactions 
(Hickey et al. 2002).  According to recent reports (Norton et al. 2006;Patil et al. 
2004;Yoon et al.2003;Klueh et al. 2007), the local release of DX can suppress the 
acute inflammation around the biosensors and may improve biocompatibility and 
prolong sensor lifetime.  The dexamethasone concentration around the implant 
depends on the drug release characterization from the matrix and must be high enough 
to prevent inflammation (Moussy et al.2006).  The drug release from equilibrium 
swollen hydrogel can be affected by both drug and materials used (Karlgard et al. 
2003).  Norton et al (Norton et al. 2005; Gallardo et al. 2001) used HEMA-VP-PEG 
hydrogel as a matrix for DX release, but there is no report about the effect of hydrogel 
compositions on DX releasing.  It has been reported that polymer structure and 
composition greatly influenced drug release, so it was a matter of importance to focus 
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on the effect of hydrogel composition on the targeted delivery of DX-21. 
In this phase of the research, a serious of porous poly(HEMA-DHPMA-VP) 
matrixes are prepared in the membrane form according to previous two chapters.  
The water soluble DX-21 was loaded into the hydrogel followed by the study to 
determine drug load and release.  The simple HPLC method was developed to detect 
both DX and DX-21 using the same mobile phase.  
4.2 Experimental 
4.2.1 Chemicals 
2-Hydroxyethyl methacrylate (HEMA) and 2, 3-dihydroxypropyl methacrylate 
(DHPMA) were donated by Benz R & D (Sarasota, FL，USA)and used as received 
without further purification.  N-Vinyl-2-Pyrrolidinone (VP) (99.9+%) was purchased 
from Sigma-Aldrich Co.( St. Louis, MO, USA) and purified by vacuum distillation to 
obtain a colorless liquid (Janson et al. 2005). Ethylene glycol dimethacrylate 
(EGDMA),   Dexamethasone-21 phosphate disodium salt (98%, powder) and 
monobasic potassium phosphate ACS grade from Sigma –Aldrich Co. (St. Louis, MO, 
USA) were used as received.  Methanol HPLC grade from Fisher Scientific (Fair 
Lawn, NJ, USA) and Benacure 1173 from Mayzon Corporation (Rochester, NY, 
USA). Phosphate buffered saline (PBS) 10X solution from Fisher Scientific (Fair 
Lawn, NJ, USA)was diluted to 1X with pH 7.4±0.1. 
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4.2.2 Drug loading by Equilibrium Partitioning 
The homemade swollen hydrogels were cut by the core bore (diameter, 
5.73mm) and freeze-dried for one day to obtain xerogel pellets which are kept in the 
descicator until used.  
Xerogel pellets were weighed, wrapped in the net and placed in individual 
vials with 3mL of 25mg/mL dexamethasone-21 phosphate disodium (DX-21) 
solutions.  The pellets were immersed in the solutions which were stirred and 
incubated in 37℃ oil bath for 24 hours. 
4.2.3 In vitro Release Study 
Drug-loaded hydrogels were removed from drug solution.  The excess 
solution on the surface of the hydrogels was removed by using Kimwipes.  
Drug loaded hydrogel were wrapped again in the net and placed into 3mL 
fresh PBS solution which was stirred and incubated in 37℃ oil bath.  PBS at 
pH7.4±0.1 at 37℃ resembles the environment of the drug inside the human body.  
At different time intervals, hydrogels were removed and placed in fresh PBS solutions 
to keep the sink condition.  The drug solutions were kept in the refrigerator prior to 
detect the DX-21 and DX concentration.  Three in vitro release studies were 
performed under the same conditions for each hydrogel sample. The means were 
calculated and graphed for each different time interval.  
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4.2.4 HPLC Analysis of DX-21 and DX Release 
4.2.4.1 Preparation of Standard Solution 
An accurately weighed quantity of DX-21 was dissolved in different mobile 
phase (Table 4.1)to obtain a known concentration of about 535.20ug/mL.  Stock 
solution was diluted to obtain 5.35, 10.70, 21.41, 42.82, 53.52, 64.22, 85.63 and 
107.04 ug/mL solution.  
A known amount of DX-21 was weighted and dissolved with mobile phase to 
obtain a known concentration of 98.80ug/mL.  The stock solution was diluted to 
obtain 79.00, 59.30, 49.40, 39.50, 19.75, 9.88 and 4.94 ug/mL solution. 
4.2.4.2 HPLC System 
The concentration of the solution was monitored by HPLC with Shimadzu 
system controller, UV-vis detector, and liquid chromatograph.  The column is 
Shimadzu premier C18 5um 150*4.6mm.  The wavelength was 241nm, and the flow 
rate was 1 mL/min.  
4.2.4.3 Selection of the Mobile Phase 
Different mobile phases were prepared according to table 4.1 and degassed by 
ultrasonic.  The mobile phase ran about half hour until the base line was stable.  
First, 39.5 ug/ml DX and 42.82 ug/ ml DX-21 were separately injected.  Second, the 
mixture of 10ml 79.00 ug/ml DX and 10ml 85.63 ug/ ml DX-21 was injected.  
De-ionized water is used to clean the tube and column for two hours.  After that a  
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new mobile phase ran about one hour before the drug solution was injected.  The 
same procedure was repeated to test different mobile phase. 
4.2.4.4 Calibration Curve and Sample Assay 
The peak area under the curve was plotted to the standard concentration to 
obtain the calibration line.  The formula derived from the line was used to calculate 
the drug concentration of the samples. 
The samples were injected to the 20uL auto valve. Every sample was injected 
at lease twice. If the error was beyond 5%, a third injection was done. The 
concentration of the solution was taken as the average value.  The mass of the drug 
equalled the average of the triple experiments. 
4.3. Results and Discussion 
4.3.1The Selection of the Mobile Phase 
Dexamethasone -21 phosphate disodium (DX-21)(Figure4.1), prodrug of 
dexamethasone, can convert to dexamethasone(DX) (Figure4.2)in biological fluids in 
vitro(Blackford et al. 2000).  During the release experiment, some DX-21 molecules 
convert to DX too.  Different mobile phases have developed to determine DX-21 and 
DX separately (Blackford et al. 2000).  It was too costly and time consuming to use 
different mobile phase to detect DX and DX-21 separately; therefore, a single mobile 
phase that could be used to detect both was necessary.  Table 4.1 shows different 
mobile phases are used to separate DX-21 and DX. 
      According to Tabel 4.1, it is seen that DX-21 is eluted earlier than DX because 
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DX-21 is more polar than DX since reverse HPLC was used.  When the polarity of 
mobile phase decreases, retention times of DX-21 and DX are extended.  When the 
ratio of methanol to water arrives at 6:4, DX-21 and DX can be separated.  They can 
further separated by mobile phase of methanol: water (5:5).  However, retentions 
time of DX-21 (2.850 and 3.175) are so short that they are close to the dead time of 
the column which is about 2min.  When the 0.01M KH2PO4 is added to the mixture, 
it makes the retention time of DX-21 longer, while the retention time of DX shorter. 
Both of the two mobile phases of methanol:water (6:4) and methanol :water(5:5) can 
separate DX-21 and DX too.  Furthermore, the peak of DX-21 can be separated from 
dead volume of column.  In order to save time, methanol: water (6:4) with 0.01M 
KH2PO4 was preferred.  Figure 4.3 shows HPLC profiles of DX-21 and DX with 
mobile phase of methanol:water(5:4, 0.01KH2PO4). 
 
Figure 4.1 structure of Dexamethasone 21-phosphate disodium 
salt(DX-21) 
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Figure 4.2 Structure of dexamethasone 
 
 
 
Table 4.1Mobile phase and Retention time 
Mobile phase 
Retention time 
DX-21 
(min) 
Retention time DX 
(min) 
100% methanol 2.075 2.117 
Methanol :water=7:3 2.658 3.392 
Methanol:water=6:4 2.850 6.725 
Methanol: water=5:5 3.175 17.342 
Methanol:water=5:5(0.01MKH2PO4) 9.942 16.625 
Methanol:water=6:4(0.01MKH2PO4) 4.533 6.558 
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Figure 4.3 A 
 
Figure 4.3 B 
 
Figure 4.3 C 
 Figure 4.3 HPLC profiles with mobile phase Methanol:water=6:4(0.01MKH2PO4): 
A.DX-21 B. DX C. DX-21 and DX 
 
Table 4.2 Regression parameters for DX and DX-21 
 formula R
2
 n* 
DX-21 3E-5x-1.0425 0.9986 21 
DX 1E-5x+0.0707 0.9880 21 
n* is the number of experiments: seven samples with three times injection each 
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Table 4.2 shows the calibration formulas of the DX-21 and DX, 
y=3E-5x-1.0425 and y=1E-5x+0.0707 separately, x is the area under the peak, and y 
is drug concentration.  The concentrations of DX-21 and DX are calculated by these 
two formulas with the area under the peak. 
4.3.2 Drug Loading by Equilibrium Partitioning  
DX has often been loaded to hydrogels by putting certain amount of DX in the 
monomer solution before polymerization because it is not water soluble (Norton et al. 
2005). With this kind of method, the obtained hydrogel can’t be purified after 
polymerization due to the loss of drug, and the drug may not stable during the 
polymerization.  For the current research effort, DX-21, pro-drug of DX-21, was 
chosen for its high water solubility.  It has been reported that highly hydrophilic 
hydrogels are useful for the release of water soluble drugs that can be immobilized in 
the hydrophilic matrix by physical entanglement (Barbu et al. 2005).  Furthermore, 
hydrogels can be loaded with water soluble drugs by partitioning it into the polymer 
matrix when the purified xerogel swells in the drug water solution after 
polymerization (Kim et al.1992).  
 
 
 
 
 
  
91 
 
Table 4.3 drug loading percents & EWCs of hydrogels with DX-21 
sample Load(%)
a
* EWC% 
D0 4.75 52.8 
D20 8.95 64.4 
D40 11.16 71.8 
D80 15.73 77.2 
VP0 13.3 73.5 
VP15 13.4 73.7 
VP30 21.2 74.6 
VP45 20.1
b*
 75.6 
a*Load(%)=Mass of total DX-21/Mass of Xerogel 
b*VP45 tears during releasing experiment  
The DX-21 loading percent is calculated by mass of cumulated release amount 
of DX-21 and DX divided by mass of xerogel.  When xerogel is immersed in the 
drug solution, drug enters to the polymer due to three types of driving forces: a drug 
concentration gradient, a polymer stress gradient and the osmotic forces (Brazel and 
Peppas, 1999).  Therefore, a higher degree of swelling is caused by the polymer 
stress gradient and osmotic forces which allow greater amounts of drug imbibed in the 
polymer matrix.  From above table 4.3, it can be seen that DX-21 loading percent 
increased with the swelling degree of hydrogels in each series.  
According to Karlgard et al.’ s work, their contact lenses only up-took about 
67±13ug DX-21 and the release could not be evaluated due to the low concentration 
of drug released.  The lowest maximum uptakes observed for DX-21 can be 
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explained by the high aqueous solubility of DX-21 which would remain preferentially 
in solution rather than within the lens material (Karlgard et al.2003).  According to 
results of table 4.3, the drug uptakes of different formulations of hydrogels are much 
more than Kalgard et al’s research.  The high aqueous solubility of DX-21 does not 
appear to be the reason for the lowest uptakes of DX-21.  This result is consistent 
with Peppas’s results regarding hydrophilic drugs.  It is reported that the amount of 
drug loaded into xerogel is a function of the partition coefficient between the drug in 
solution and the gel itself, hydrophilic drugs which are more soluble in the loading 
solutions are loaded to higher concentration into polymer samples (Brazel and Peppas, 
1999). 
4.3.3 Drug Release 
After surgical implantation of the glucose sensors, the acute inflammatory 
response normally takes place within seconds.  During the initial stage, proteins and 
inflammatory cells adsorb to the sensor surface.  Phagocytic cells (e.g., neutrophils, 
monocytes, and macropages) then surround the device within minutes to hours in an 
effort to destroy it.  Such membrane biofouling is detrimental to sensor function 
resulting in restriction of analyte diffusion to the sensor and/or degradation of the 
sensor membrane (Shin and Schoenfisch, 2006).  If the acute inflammation cannot be 
suppressed, the chronic inflammation will be sustained from weeks to lifetime.  This 
may result in the forming of fibrosis around the implanted glucose sensors and enable 
the implanted glucose sensors lose the valid function (Shin and Schoenfisch, 2006).  
In order to prevent the acute inflammation and prolong the lifetime of the implanted 
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glucose sensors, both penetration rate and concentration of anti-inflammatory drug 
around the tissue should be high enough to suppress the inflammation (Moussy et al. 
2006).  According to the results from figure 4.4 and 4.5, all hydrogels showed a high 
initial release, followed by slow, long term release during the next hours to days.  
This function is believed to be good for the implanted glucose sensors to suppress the 
acute inflammation and chronic inflammation.  
Drug release kinetics from hydrogels can be expressed by the following 
equation (4-1): 
M
M t =kt
n
   (4-1) 
Where Mt is the amount of release at time t, M is the initial drug loading, 
M
M t is the fraction of drug released, t is the release time, n, drug release exponent, and 
k is a constant incorporating the structural and geometrical characteristics of the 
release device.  It has been reported that n=1 is Case II release kinetics and n=0.5 
corresponds to the Fickian release kinetics (Ritger and Peppas, 1987).  The values of 
n were derived from the linear regression slopes of the release profiles (Mt/ M ) <0.6 
using above equation shown in Figure 4.5.  It shows that n is about 0.5 which 
indicates the release mechanism is Fickian diffusion. 
Average DX-21 release rates from hydrogels can be expressed by the 
diffusion coefficient.  All sample shapes are similar and the ratio of thickness (L) to 
diameter (Di) is about 1:6.5.  It is assumed that water diffuses into a planar sheet at a 
constant rate. When 
M
M t ≤0.5 the relationship between 
M
M t and time will fit 
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equation 5 (Kim et al. 1980).
  
M
M t = 
L
4
(

Dt
)
 0.5
                                         (4-2) 
The diffusion coefficient (D) values were estimated according to equation (5) 
and shown in Figure 4.6 and Table 4.4.  From Table 4.4 it can be seen that average 
DX-21 release rates from DHPMA series hydrogels increases with DHPMA content 
due to higher equilibrium water content, initial DX-21 loaded percent and more pores. 
The higher initial drug loaded percent causes higher concentration gradient between 
hydrogel and fresh PBS solution which acts as the driving force for the drug diffusion. 
The pores of polymers work as a tunnel for drug transport.  Since water is the 
vehicle to transport the drug out of polymer, higher water content will facilitate drug 
diffusion.  Factors influencing drug releasing behavior is related to the drug uptaking 
behavior: concentration gradient, equilibrium water content and pores which are 
dictated by polymer composition.  
For VP series hydrogels, average release rates of VP15 and VP30 are lower 
than VP0 and VP45.  According to SEM figures 3.4, there are nets that appear on the 
surface of pores.  These nets may work to block DX-21 transport out of the hydrogel. 
There are more nets on the surface of VP30 pores than in VP15.  The average release 
rate of VP30 is also slower than VP15. This confirms that the polymer 
inner-morphology is another factor that greatly influences drug diffusion. 
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Figure 4.4 A initial burst release 
 
Figure 4.4 B low level long term release 
Figure 4.4 DX-21Cumulative release profiles from DHPMA hydrogels 
 
 
 
  
96 
 
Figure 4.5 A initial burst release 
 
Figure 4.5 B low level long term release 
Figure 4.5 DX-21Cumulative release profiles from VP hydrogels 
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A. DHPMA series 
 
B. VP series 
Figure 4.6 Drug release kinetics log(Mt/Meq) versus log Time 
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Table 4.4 DX-21 release exponents and coefficients 
 
 n R
2
 D(ҳ108cm2S-1) 
D0 0.4394 0.9958 2.60±0.08 
D20 0.4964 0.9970 13.80±0.13 
D40 0.4177 0.9987 21.76±1.03 
D80 0.4780 0.9969 62.36±4.04 
VP0 0.5649 0.9980 38.37±1.12 
VP15 0.5022 0.9995 33.70±2.54 
VP30 0.4422 0.9999 27.67±0.23 
VP45 0.4193 0.9999 52.30±2.72 
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4.4. Conclusion 
The mobile phase methanol:water=6:4(0.01MKH2PO4) could separate DX and 
DX-21 at the same run so it is available to detect both DX and DX-21 by a simple 
HPLC method. 
DX-21 was successfully loaded into a series of hydrogels by equilibrium 
partitioning.  The drug loaded percents show that D80 could uptake the maximum 
DX-21 due to high equilibrium water content and more pores.  The drug release 
kinetics shows that DX-21 releasing mechanism from novel hydrogels is Fickian 
diffusion.  The factors influence drug releasing behavior is relative to drug uptaking 
behavior: concentration gradient, inner-morphology and water content which are 
decided by polymer composition. 
 
 
 
 
 
 
 
 
 
 
  
100 
 
 
CHAPTER 5 
WATER STRUCTURE IN HYDROGELS 
5.1. Introduction  
The study of water structure in the hydrogels can assist in determining the 
biocompatibility of the hydrogel and affect the transportation of the molecules 
between the matrix and intermediate.  An investigation of water structure in a 
polymer yields valuable information on the sorption, diffusion and permeation 
properties of molecular species in hydrophilic polymers.(Ping et al. 2001)  Most 
research on water structure in hydrogels has focused on the water in hydrogels using 
deionized water or PBS solution as media (Goda et al.2006; Liu and Huglin, 2003; 
Ping et al. 2001;Ahmad and Huglin, 1994).  Research conducted by Stevenson and 
Gates compared water structures in hydrogels at equilibrium in different media such 
as water and PBS (Stevenson and Sefton,1988; Gates and Harmon, 2001). However, 
there is no report about water structure in hydrogels which swell to reach equilibrium 
when immersed in drug solution. 
Water structure in hydrogels can be detected by differential scanning 
calorimetry (DSC)(Murphy et al. 1988; Pedley and Tighe, 1979),NMR (Chowdhury et 
al. 2004;Capitani et al. 2001), dilatometry, electrical conductivity (Lee et al. 
1975;Choi et al. 1977), dielectric relaxation spectroscopy (Kyritsis et al. 1995), and 
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dynamic-mechanical spectroscopy (Lustig et al. 1991).  The most common method 
is DSC. Using DSC, water in a hydrogel is classified as free water, freezing bound 
water and nonfreezing water. Free water does not take part in hydrogen bonding with 
polymer molecules. It has a similar transition temperature, enthalpy and DSC curves 
as pure water (Nakamura et al. 1983).  Freezing bound water interacts weakly with 
polymer molecules and has a phase transition temperature lower than 273K. 
Non-freezing bound water is complexed with the polymer chain through hydrogen 
bonds and has no detectable phase transition over the temperature range from 200K to 
273K (Higuchi et al. 1984).  
It was previously discussed that equilibrium water content of the hydrogel is 
one important factor affecting drug diffusion.  It is known that freezing water content 
is essential for predicting efficient diffusion of salts and macromolecules (Pedley D.G. 
and Tighe 1979). Hydrogel coatings loaded with DX-21will be implanted and come in 
contact with different body fluids which contain many small water soluble molecules. 
When these small molecules diffuse into hydrogels and DX-21 molecules diffuse out 
of hydrogels, the water content and structure in hydrogels may change too.  
Therefore, it is very important to investigate the water structure in hydrogels at 
equilibrium in small molecule media and DX-21 solution. In this chapter, 
1HEMA:1DHPMA copolymer and 3 VP-HEMA-DHPMA copolymers were used to 
study the water structure. PBS was chosen as the media for small molecules because it 
is similar to body fluid. The water structures of these hydrogels were studied by DSC. 
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5.2. Experimental 
5.2.1. Chemicals 
Four different polymers were prepared as described in chapter 3: one 
HEMA-DHPMA copolymer and three VP-HEMA-DHPMA copolymers. 
Dexamethasone-21 phosphate disodium salt (98%, powder) ACS grade was purchased 
from Sigma –Aldrich Co. (St. Louis, MO, USA) was used as received. Phosphate 
buffered saline (PBS, 11.9mM Phosphate, 137mM Sodium Chloride, 2.7mM 
Potassium Chloride) 10X solution from Fisher Scientific (Fair Lawn, NJ, USA) was 
diluted to 1X with pH 7.4±0.1. 
 
5.2.2. Instrumentation 
All water structure data were obtained by measuring heat flow with a TA 
Instruments 2920 differential scanning calorimeter (DSC). DSC measures heat flow 
and temperature between a sample and reference as a function of time and 
temperature. The reference is an empty hermetic aluminum pan of similar weight to 
that of the sample pan. The DSC was calibrated from -100℃ to 200℃ at 5℃/min 
heating rate for baseline and temperature using an indium standard. 
Hydrogels were analyzed by cooling the sample from 20℃ to -80℃, and a 
one minute isothermal period at -80℃, and heating the sample from -80℃ to 20℃at 
5 ℃/min.  The water fractions for hydrated samples were reported as the water mass 
over xerogel mass.  The total integrated area of the respective endotherm peak 
represents the melting enthalpy.  The melting enthalpy was plotted as a function of 
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total water fraction, and the amount of nonfreezing water was determined by the water 
fraction intercept of the linear plot. 
 
5.2.3. Method 
The drug loading and releasing method are the same as previously discussed. 
The equilibrium water fraction (EWF) was determined by the mass of water divided 
by the mass of xerogel. 
Freeze-dried were equilibrated swollen in de-ionized water, 1X PBS solution, 
25mg/ml DX-21 solution at atmospheric conditions, 23℃ and 55% relative humidity.  
The samples analyzed by DSC were cut from the swollen hydrogels with #1 
cork bore and placed in media to reach equilibrium. For the partially hydrated samples, 
some water was allowed to evaporate and then the samples were sealed in the pans to 
equilibrate. The equilibrium samples were quickly weighed to ±0.01mg and 
immediately analyzed by DSC. The sample mass ranged from 5 to 15mg. After DSC 
analysis, the samples were removed from the hermetic pans, oven dried to obtain the 
dry polymer mass. The water mass was determined by subtracting the xerogel mass 
from the mass of the hydrated DSC sample. 
 
5.3. Results and discussion 
5.3.1 Equilibrium Water Fraction of Hydrogel Before and After DX-21Releae 
The equilibrium water fraction of hydrogels were determined when swollen to 
equilibrium in DX-21 water solution and when DX-21 loaded hydrogels released 
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DX-21 completely in PBS solution at 37 ℃. This data are listed in Table 5.1. 
From Figure 5.1 it can be seen that when DX-21 is released, the hydrogels 
shrink. Before the release of the drug, the equilibrium water fraction of hydrogel is 
more than after the release. From this it was apparent that when DX-21 is released 
from the hydrogel, some water also moves out of the hydrogel and causes shrinkage. 
It can be concluded that not only the composition of hydrogel, but also solutes affect 
the water content of the hydrogel. Further research will focus on studying the water 
structure in hydrogel at the equilibrium state in different media. 
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Figure 5.1 Potos of hydrogel loaded with DX-21(A) and hydrogel released 
DX-21(B) 
 
 
 
Table 5.1 Equilibrium water fractions of DX-21 loaded hydrogels at 
equilibrium before and after the release of the drug in PBS solution at 37
0
C (means ± 
SD, n=3) 
 EWF(with DX-21) EWF(released DX-21) 
VP15 2.91±0.17 1.49±0.11 
VP30 4.25±0.09 2.17±0.23 
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5.3.2 Water Structure of the HEMA-DHPMA Copolymer 
HEMA-DHPMA copolymer was made by 1:1 molar ratio of HEMA and 
DHPMA.  Table 5.2 shows EWFs of HEMA-DHPMA copolymer swollen in 
different media. 
Table 5.2 EWF and NFWF of 1HEMA:1DHPMA copolymer 
 
sample EWF NFWF  
water 1.7465 0.5806 
PBS 1.6913 0.4814 
DX-21 2.7737 0.4239 
According to table 5.2 results, HEMA-DHPMA copolymer exhibits a lower 
EWF in PBS solution than in deionized water.  This is different from the results 
reported by other researchers (Stevenson, 1988; Gates, 2001).  Stevenson found that 
EWFs of polyHEMA, and poly(HEMA-co-MMA) were much higher in PBS than in 
distilled water.  Gates reported that HEMA-DHPMA copolymer exhibited the same 
equilibrium water content in de-ionized water as well as in saline solution.  These 
results are not consistent which may imply that the equilibrium water content of 
hydrogel in PBS solution depends on the gel composition and crosslink ratio. 
HEMA-DHPMA copolymer imbibed more equilibrium water in the DX-21 
solution than in PBS solution and de-ionized water.  This may be due to 
incorporation of large molecule DX-21 which weakens the secondary bonds within 
the hydrogel, enlarging the distance between the polymer chains and causing an 
uptake of water.  Thus the equilibrium water content of hydrogel in DX-21 is much 
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more than in PBS solution and water.  This result is similar to the above result when 
DX-21 released from hydrogel along with water.  
HEMA-DHPMA copolymer at equilibrium and at various states of partial 
hydration was analyzed by DSC (Figure 5.2).  When hydrogels were swollen in 
de-ionized water, two crystallization exotherm peaks, assigned as Tc1 at higher 
temperature and Tc2 at lower temperature, are shown in cooling curves.  The 
integrated area of lower temperature exotherm is greater than the higher temperature 
at equilibrium in deionized water.  At initial dehydration stage, a third exotherm 
peak is seen at Tc3 which is lower than Tc1 and Tc2, and both Tc1 and Tc2 are the same 
as equilibrium.  When the material continued desorption, all crystallization 
temperatures Tc1, Tc2 and Tc3 decreased.  These results are consistent with previous 
research (G. Gates and J. Harmon, 2001). 
When hydrogels were swollen in PBS solution, there is one crystallization 
exotherm (Tc1) with a lower temperature shoulder at equilibrium.  The shoulder 
progressively separates from the Tc1 and moved to lower temperature during 
desorption.  
There is only one crystallization exotherm (Tc1) at equilibrium during initial 
dehydration in DX-21 solution.  Tc1 moved to lower temperature and one new 
crystallization peak (Tc2) appeared when dehydration process continued. 
In summary, the crystallization of water inside the hydrogel appears to be 
dependent of the water fraction of hydrogel.  At high water fraction, only one 
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transition peak is present, and more transitions appear as water fraction decreases.  
At higher water fractions, there is only one sharp peak indicating the perfect 
crystallization of water. With lower water fraction, one or two more crystallizing 
peaks appeared.  The reduced swelling and shrinkage during the process of 
dehydration can restrict the mobility of the water due to stronger interactions with 
polymer or water.  This makes it harder to form perfect crystals, so broader peaks 
appeared in lower temperatures instead of sharp peaks. 
There are two transitions observed in the heating curves at different water 
fractions when HEMA-DHPMA copolymer is swollen in water and PBS solution.  
The temperature Tm1 (transition near 273K) was assigned for free freezing water, and 
temperature Tm2 for freezable bound water (transition near 263K) (Ahmad and 
Huglin ,1994).  From the transitions of different water fractions swollen in DX-21, it 
can be seen that when EWF is over 2.36, the two peaks merge progressively to 
become a broad peak. Such a broad endothermic peak was also observed in other 
hydrophilic polymers (Ping et al. 2001;Wycisk and Trochimczuk,1992;Tasaka et al. 
1988;Zhang et al. 1989;Fushimi et al. 1991;Hatada et al. 1982) 
Ahmad M. B. reported that the appearance of the second transition at Tm2 
seemed to be dependent of the amount of water absorbed by the hydrogels while there 
is no evidence for Tm1 to deviating from 273 K.  Ping reported that the melting point 
of freezable bound water increased linearly with the water content in PVA hydrogels 
and explained that the lowering of the freezable bound water melting point was due to 
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the increase in the overall hydrogen bonding ability of the polymer (Ping et al. 2001). 
Baker reported that the thermal transition temperature for free freezing water was 
found to decrease with decreasing water content (Fushimi et al. 1991).  For the 
present results, both peak maximum temperatures Tm1 and Tm2 decreased with 
decreasing water fraction.  These heating results are consistent with our cooling 
results, because in the cooling process imperfect ice crystals formed during the 
dehydration process, were unstable compared to the perfect crystals and melt at lower 
temperatures.  
A decrease in separation (Tm1-Tm2) of peak maximum temperatures with 
increasing EWC has been reported by (Higuchi and Iijima,1985), but the separation 
did not decrease consistently with increasing EWC was also reported by Ahmad M. B. 
(Ahmad,1994).  These reports were not in agreement with each other, which may be 
due to different polymer compositions with different EWC.  In present study, the 
separation was studied based on the same formulation with different water contents. 
The results showed that separation (Tm1-Tm2) (Table 5.3) increased with increasing 
water fraction contrary to what was reported by Higuchi (Higuchi and Iijima,1985).  
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Table 5.3 Water melting points of hydrogels at different water fractions 
 
 WF Tm1(℃) Tm2(℃) Tm1-Tm2 
VP0(water) 1.74 5.62 -5.13 10.75 
VP0-1(water) 1.58 3.45 -5.67 9.12 
VP0-2(water) 1.20 2.03 -5.84 7.87 
VP0-3(water) 0.88 -0.22 -6.13 5.91 
VP0(PBS) 1.69 3.06   
VP0-1(PBS) 1.51 3.14 -7.63 10.77 
VP0-2(PBS) 1.41 1.84 -8.15 9.99 
VP0-3(PBS) 1.27 0.61 -8.67 9.28 
VP0-4(PBS) 0.89 -0.22 -8.93 8.71 
VP0(DX21) 2.77 6.49   
VP0-1(DX21) 2.36 4.96   
VP0-2(DX21) 1.62 2.96 -6.20 9.16 
VP0-3(DX21) 1.14  -7.64  
VP0-4(DX21) 0.81 -0.24 -8.37 8.13 
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Figure 5.2 DSC cooling and heating curves for 1HEMA:1DHPMA copolymer at 
various stages during desorption of deionized water, PBS solution and DX-21 
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Since the nonfreezing water fraction can be defined as the limiting value of 
water fraction at zero enthalpy of fusion (Vaquez et al. 1997), the enthalpy (integrated 
area) of melting endotherms from the DSC data was used to determine the 
nonfreezing water fraction by extrapolation.  Linear plots of the total endotherm area 
as a function of water fraction are presented in figure 5.3, 5.4, 5.5.  The water 
fraction intercept was used as the fraction of nonfreezing water (NFWF) and shown in 
Table 5.2.  This is different from Gates’s result which reports that nonfreezing water 
fractions in water and PBS solution are almost the same. This may be due to different 
PBS solution and different crosslink ratio of 1HEMA:1DHPMA copolymer.  
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Figure 5.3 Linear plot of total integrated endotherm area versus total water fraction 
for the 1 HEMA:1 DHPMA copolymer swollen in deionized water 
 
Figure 5.4 Linear plot of total integrated endotherm area versus total water fraction 
for the 1 HEMA:1 DHPMA copolymer swollen in PBS solution 
 
Figure 5.5 Linear plot of total integrated endotherm area versus total water 
  fraction for the 1 HEMA:1 DHPMA copolymer swollen in DX-21 solution 
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5.3.3. Water Structure of VP-HEMA-DHPMA Copolymer Hydrogels 
Based on 1HEMA:1DHPMA copolymer, different molar ratios (15, 30, 45) of 
VP were copolymerized with 1HEMA:1DHPMA monomers to obtain 
VP-HEMA-DHPMA copolymer, VP15, VP30, VP45.  Equilibrium water fractions of 
VP15, VP30 and VP45 were determined by mass of water divided by mass of xerogel 
and listed in Table 5.4.  Water structures of VP-HEMA-DHPMA copolymer swollen 
in de-ionized water, PBS solution and DX-21 solution were studied by DSC.  Linear 
plots of the total endotherm area as a function of water fraction are presented in figure 
5.6, 5.7, 5.8.  The water fraction intercept was used as the fraction of nonfreezing 
water (NFWF) and shown in Table 5.6.  Freezing water fraction was determined by 
subtracting nonfreezing water fraction from equilibrium water fraction (Table5.7). 
      All VP-HEMA-DHPMA copolymers exhibited highest equilibrium water 
fractions in DX-21 and lowest in PBS solution.  This result is the same as the 
1HEMA:1DHPMA copolymer.  The low equilibrium water content of hydrogel is 
usually improved by copolymerizing more hydrophilic monomers.  It seems that 
large water soluble salts such as DX-21 also can increase the equilibrium water 
content of hydrogel.  
      Table 5.5 shows values of the difference of water mass between the hydrogels 
at equilibrium in DX-21 and PBS solution divided by mass of DX-21 loaded in 
hydrogel.  For DX-21 all values are about 9.6 which is independent of polymer 
compositions. This offers a new and simple method to estimate the drug loading 
amount in hydrogels.  
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Table 5.4 EWF of VP-HEMA-DHPMA copolymer 
 
sample PBS water DX-21 
VP15 1.6947 1.8122 2.8036 
VP30 1.8709 2.0100 2.9346 
VP45 1.8890 2.2428 3.1004 
 
 
Table 5.5 Vlues of Δwater mass(g) / DX-21mass(g) 
 
Hydrogel 
 
Δwater mass(g) / 
DX-21mass(g)  
VP15 9.6 
VP30 9.6 
VP45 9.6 
 
 
 
 
 
 
 
  
120 
 
 
 
Figure 5.6 Linear plot of total integrated endotherm area versus total water 
  fraction for the VP15 copolymer swollen in water, PBS and DX-21 solution 
  
121 
 
 
 
Figure 5.7 Linear plot of total integrated endotherm area versus total water 
  fraction for the VP15 copolymer swollen in water, PBS and DX-21 solution 
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Figure 5.8 Linear plot of total integrated endotherm area versus total water 
  fraction for the VP15 copolymer swollen in water, PBS and DX-21 solution 
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Table 5.6 NFWF of VP-HEMA-DHPMA copolymer 
 
sample PBS water DX-21 
VP15 0.4581 0.4120 0.4756 
VP30 0.4291 0.3791 0.4798 
VP45 0.4301 0.3186 0.5112 
 
Table 5.7 FWF of VP-HEMA-DHPMA copolymer 
 
sample PBS water DX-21 
VP15 1.2366 1.4002 2.3280 
VP30 1.4418 1.6309 2.4548 
VP45 1.4589 1.9242 2.5892 
 
When the hydrogels are at equilibrium in PBS solution and water, 
non-freezing water content decreased with the increase of the VP content even though 
the whole water content increase. A similar decrease has also been found for the 
poly(VP-MMA) hydrogels (Liu and Huglin, 1995). Liu tried to explain that the 
decrease of nonfreezing water content was due to the increase of water content 
according to different swelling time. This was an obvious fact because the same 
formulation swells at different time when nonfreezing water content is expressed 
relative to the mass of the hydrogel. However, this explanation is not reasonable when 
nonfreezing water content is expressed relative to the mass of xerogel. This 
explanation also does not explain the relation of the nonfreezing water content and VP 
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content, thus there is no definitive explanation for this trend. However, following are 
two possible explanations. 
One explanation for the observed trend may be that when VP content 
increased, more H-bond formed between the polymer chains as evident by the 
increase of the glass transition temperature (chapter 3). Since nonfreezing water is the 
H-bond water formed between water and polymer chain, the inter-chain H-bond 
reduced the total available sites to form H-bond with water molecules. Thus, the 
amount of non-freezing bond water decreases with increasing VP content.  
Another possible explanation for present polymers is that different average 
number of non-freezing water molecules per site. From the following table, it can be 
seen that average number of non-freezing water molecules per VP is 4.2, per HEMA 
is 4.1 and per DHPMA is 6.4. Since the molar ratio of HEMA and DHPMA is 1:1, so 
the average number of non-freezing water molecules per (HEMA-DHPMA) is 5.25 
which is larger than VP. Thus when VP content increased, the number of non-freezing 
water molecules decreased which lead to the decrease of nonfreezing water content. 
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Table 5.8 Molar ratios of non-freezing bound water in different polymers 
 
polymers Nnf/Np 
PVP* 4.2 
PHEMA* 4.1 
PDHPMA* 6.4 
*PHEMA and PDHPMA results were calculated from the reference (Gates and 
Harmon, 2001) 
*PVP result was obtained from the reference (Ping et al. 2001) 
From table 5.6 it also can be seen that all VP contained samples showed higher 
nonfreezing water content in PBS solution than in de-ionized water which is different 
from 1HEMA:1DHPMA copolymer.  Without VP, the salt ions interfere with the OH 
groups on the polymer chain thereby reducing the number of H-bonding sites 
available to water. VP in the polymer chain blocks the salts from interfering with the 
H-bonding sites thus allowing water to H-bond with the polymer. Thus more 
H-bonding sites are created and higher nonfreezing water content was seen. 
When VP contained gels were swollen to reach equilibrium in DX-21, 
hydrogels exhibited more FWF and NFWF than in de-ionized water and PBS solution.  
The additional nonfreezing water content could be from H-bonding water with the 
DX-21 since DX-21 molecules contain polar groups such as O, F, and OH.  When 
more DX-21 molecules entered into the polymer matrix, they also bring in more free 
water to the matrix.  The incorporation of large DX-21 molecules can strengthen the 
distance of the polymer chain and let more freezable water enter into the matrix. 
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5.4. Conclusion 
Equilibrium water fraction of drug loaded hydrogel is bigger than that of drug 
released hydrogel, which is confirmed by the shrinkage of hydrogel.  This result 
implies that both the composition of the hydrogel and the solutes can affect the water 
structure.  
1HEMA:1DHPMA copolymer and VP-HEMA-DHPMA copolymers imbibed 
highest equilibrium water fraction in DX-21 solution, lowest equilibrium water 
fraction in PBS solution.  During dehydration process, crystallization exotherms and 
melting endotherms of 1HEMA:1 DHPMA copolymer in all different media moved to 
lower temperatures due to the shrinkage of hydrogel causeing imperfect ice crystals to 
form, and a decrease in separation (Tm1-Tm2).  
For VP-HEMA-DHPMA copolymer, the non-freezing water fraction decreases 
with an increase of VP at equilibrium state in water and PBS solution even though the 
equilibrium water fraction increased.  This trend is explained by the decrease of 
H-bond sites with water and less molar ratio of nonfreezing water per molecule when 
compared to 1HMEA:1DHPMA. Both non-freezing water fraction and freezing water 
fraction of VP contained hydrogels are higher in DX-21 solution than in PBS and 
water.  The information offers a new way to increase the low water content hydrogel 
by swelling xerogels in media containing large water soluble molecules.  Since 
DX-21 molecules contain polar groups such as OH, F and O, it can bring some 
H-bond water into the matrix.  When the distance between the polymer chains is 
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increased, more free water will be incorporated. 
Since the ratio of transporting water mass to DX-21 mass is 9.6 which is 
independent of hydrogel compositions, the DX-21 load can also be estimated by the 
difference of equilibrium water content of hydrogel swollen in DX-21 solution and 
PBS solution. 
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CHAPTER 6 
SUMMARY AND SUGGESTIONS FOR FUTURE STUDY 
6.1. Summary 
State of the art implantable glucose sensors do not work reliably and have a 
rather short life after implantation (Moussy, 2002).  This in vivo loss of function is 
caused by tissue reactions surrounding the sensor such as fibrosis and inflammation 
(Mang et al, 2005).  It is believed that the performance of implanted glucose sensors 
can greatly benefit from the use of more biocompatible outer most coatings.  
Therefore, in order to improve the lifetime of implantable glucose sensors, two 
different novel series of hydrogel coatings were designed, synthesized and 
characterized for use on implantable glucose sensors.  
During this effort novel hydrogel polymers with various DHPMA content 
were prepared, characterized, and coated onto implantable glucose sensors and then 
tested in vitro and in vivo.  The effects of 2,3-dihydroxypropyl methacrylate 
(DHPMA) on the swelling, morphology, glass transition(Tg), and water structure were 
studied.  The results show that the degree of swelling increases with increasing 
DHPMA content.  Scanning electron microscopy (SEM) studies identified uniform, 
porous structures in samples containing 60-90 mole % DHPMA.  Glass transition 
temperatures did not change significantly with DHPMA content, but the ratio of 
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freezing to nonfreezing water tended to increase with DHPMA content.  Sensors 
coated with different hydrogels were prepared and in vitro evaluations were 
performed.  The 80% DHPMEA hydrogels exhibited optimum sensitivity, response 
and stability when coated directly onto the sensor or top of a polyurethane (PU) layer. 
The histology results show that 80% DHPMA samples exhibit reduced fibrosis and 
inflammation.  Eight D80 coated Pt/GOX/epoxy-polyurethane glucose sensors were 
implanted into 4 rats (2 sensors/rat).  The original attempt of in vivo implanted 
glucose sensors was not successful, because only 25% of the sensors were working at 
4 weeks.  In order to further improve the efficiency of implanted glucose sensors, 
another series of novel hydrogels were developed based on copolymer of HEMA and 
DHPMA.  The porosity and mechanical properties of the hydrogels were improved 
using VP and EGDMA. The results of SEM, DSC, and FT-IR analysed show that the 
hydrogel (VP30) produced from a monomeric mixture of 69% (1HEMA:1DHPMA), 
30% VP and 1% EDGMA (mol%) had a more uniform pore structure and net structure, 
high water content at swelling equilibrium (EWF = 166% by mass) and acceptable 
mechanical properties.  Two kinds of VP30-coated sensors, Pt/GOx/VP30 and 
Pt/GOx/epoxy-polyurethane (EPU)/VP30 sensors were examined in glucose solutions 
during a period of 4 weeks.  The Pt/GOx/VP30 sensors produce large response 
currents but the response linearity was poor.  Therefore, further studies were focused 
on the Pt/GOx/EPU/VP30 sensors. With a diffusion-limiting epoxy-polyurethane 
membrane, the linearity was improved (2–30 mM) and the response time was within 5 
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min.  Eight Pt/GOx/EPU/VP30 sensors were subcutaneously implanted in rats and 
tested once per week over 4 weeks.  All of the implanted sensors kept functioning 
for at least 21 days and 3 out of 8 sensors still functioned at day 28.  Histology 
revealed that the fibrous capsules surrounding hydrogel-coated sensors were thinner 
than those surrounding Pt/GOx/EPU sensors after 28 days of implantation. 
It was discussed that the biocompatibility of glucose sensors was improved by 
hydrogel.  However, there is still a small amount of inflammation and fibrosis 
occuring within the tissue around the implanted glucose sensors after 4 weeks. 
According to recent reports (Norton et al, 2006; Patil et al, 2004; Yoon et al,2003; 
Klueh et al, 2007), the local release of DX can suppress the acute inflammation 
around the biosensors and may improve biocompatibility and prolong sensor lifetime. 
In order to further suppress the biofouling process, Dexamethasone-21 phosphate 
disodium salt (DX-21) was incorporated to the hydrogel to do the targeted drug 
delivery research.  DX-21 was successfully loaded into a series of hydrogels by 
equilibrium partitioning.  The drug release kinetics shows that DX-21 releasing 
mechanism from novel hydrogels is Fickian diffusion.  The factors influence drug 
releasing behavior is relative to drug uptaking behavior: concentration gradient, 
inner-morphology and water content which are decided by polymer composition.  
All hydrogels showed a high initial release, followed by slow, long term release 
during the next hours to days.  This function is believed to be good for the implanted 
glucose sensors to suppress the acute inflammation and chronic inflammation. 
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During the release experiment, some DX-21(Figure4.1) molecules convert to 
DX (Figure 4.2). Different mobile phases have been developed to determine DX-21 
and DX separately (Blackford et al, 2000). It was too costly and time consuming to 
use different mobile phase to detect DX and DX-21 separately; therefore, a single 
mobile phase methanol:water=6:4(0.01MKH2PO4) that could be used to detect both 
was created. 
The structure of water in the hydrogel can determine the biocompatibility of 
the hydrogel and affect the transportation of the molecules between the matrix and 
intermediate.  The investigations on the structure of water in a polymer can give 
valuable information on the sorption, diffusion and permeation properties of 
molecular species in hydrophilic polymers (Ping et al. 2001). The water structure in 
hydrogels swollen in different media including water, PBS and DX-21 solution were 
investigated.  Results show that equilibrium water fraction of drug loaded hydrogel 
is larger than that of drug released hydrogel, which is confirmed by the shrinkage of 
hydrogel.  This result implied both the composition of hydrogel and solutes can 
affect the water structure in the hydrogel.  
1HEMA:1DHPMA copolymer and VP-HEMA-DHPMA copolymers imbibed 
highest equilibrium water fraction in DX-21 solution, lowest equilibrium water 
fraction in PBS solution.  This information offers a new way to increase the low 
water content of hydrogel by swelling xerogels in large water soluble molecules 
media.  Since the ratio of transporting water mass to DX-21 mass is 9.6 which is 
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independent of the hydrogel composition, the DX-21 load can be estimated by the 
difference of equilibrium water content of hydrogel swells in DX-21 solution and PBS 
solution. 
During dehydration process, crystallization exotherms and melting endotherms 
of 1HEMA:1 DHPMA copolymer in all the different media moved to lower 
temperatures due to the shrinkage of hydrogel which causes imperfect ice crystals, at 
the same time separation (Tm1-Tm2) decreased too. 
For VP-HEMA-DHPMA copolymer, the non-freezing water fraction decreases 
with VP increases at equilibrium state in water and PBS solution even though the 
equilibrium water fraction increases.  This trend is explained by the decrease of 
H-bond sites with water and less molar ratio of nonfreezing water per molecule.  
Both non-freezing water fraction and freezing water fraction of VP contained 
hydrogels are higher in DX-21 solution than in PBS and water.  
 
6.2. Suggestions for Future Works 
The efficiency of implanted glucose sensors has been enhanced by novel 
hydrogel coatings.  However, there is still some inflammation processes and fibrosis 
that occurs to the tissue around implanted glucose sensor. The drug delivery in vitro 
study shows that DX-21 loaded hydrogel should effectively suppress acute 
inflammation and chronic inflammation. In a future study, drug loaded hydrogel 
coated glucose sensors will be implanted into rats and determine the performance of 
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the implanted glucose sensors. 
It has been reported that controlled neovascularization around sensor by 
angiogenic growth factors such as VEGF can improve the performance of implanted 
glucose sensors (Klueh et al.2003,2005).  The pores structures inside the hydrogel 
can be useful for locating nanoparticles or microspheres for controlled drug release 
system.  The future goal of more studies will be to incorporate VEGF loaded 
microspheres or nanoparticles to these novel pores matrix.  At last a dual release 
system for both DX-21 in the hydrogel and VEGF in microspheres will be realized.  
It has been reported that DX can lead to an anti-angiogenesis effect along with an 
anti-inflammatory response.  The initial burse release of DX-21 from this new dual 
release system can suppress the acute inflammation.  VEGF will be released slowly 
form microspheres and nanoparticle accompanied by low level release of DX-21 
which can not greatly affect the angiogenesis.  
Since these novel hydrogel coatings improved the biocompatibility of 
implanted glucose sensors, they have the potential use for other implantable 
biosensors.  A future study can also be focused on the modification of these novel 
hydrogel coatings for other implantable biosensors. 
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Appendix A: Chapter 2, DSC curves 
 
Figure A-1.DSC curve for glass transition of D0 sample 
 
 
Figure A-2. DSC curve for glass transition of D20 sample 
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Appendix A (continued) 
 
Figure A-3. DSC curve for glass transition of D40 sample 
 
Figure A-4. DSC curve for glass transition of D60 sample 
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Appendix A (continued) 
 
Figure A-5. DSC curve for glass transition of D80 sample  
 
Figure A-6. DSC curve for glass transition of D90 sample 
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Appendix A (continued) 
 
Figure A-7. DSC curve for water structure of D0 with 48.8% EWC  
 
Figure A-8. DSC curve for water structure of D20 with 52.0% EWC 
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Appendix A (continued) 
 
Figure A-9. DSC curve for water structure of D40 with 60.1% EWC 
 
Figure A-10. DSC curve for water structure of D60 with 65.5% 
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Appendix A (continued) 
 
Figure A-11. DSC curve for water structure of D80 with 69.4% EWC 
 
Figure A-12. DSC curve for water structure of D90 with 69.9% EWC 
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Appendix B: Chapter 5 
 
Figure B-1 DSC curve for water structure of VP15 swollen in water with 1.8122 EWF 
 
Figure B-2 DSC curve for water structure of VP15 swollen in water with 1.6144 EWF 
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Appendix B (Continued) 
 
Figure B-3 DSC curve for water structure of VP15 swollen in water with 1.3636 EWF  
 
Figure B-4 DSC curve for water structure of VP15 swollen in water with 1.0245 EWF 
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Appendix B (Continued) 
 
Figure B-5 DSC curve for water structure of VP15 swollen in water with 0.5908 EWF 
 
Figure B-6 DSC curve for water structure of VP15 swollen in PBS with 1.6947 EWF 
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Appendix B (Continued) 
 
Figure B-7 DSC curve for water structure of VP15 swollen in PBS with 1.3817 EWF 
 
Figure B-8 DSC curve for water structure of VP15 swollen in PBS with 1.0981 EWF 
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Appendix B (Continued) 
 
Figure B-9 DSC curve for water structure of VP15 swollen in DX-21 with 2.8036 
EWF 
 
Figure B-10 DSC curve for water structure of VP15 swollen in DX-21 with 2.3937 
EWF 
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Appendix B (Continued) 
 
Figure B-11 DSC curve for water structure of VP15 swollen in DX-21 with 1.3192 
EWF 
 
Figure B-12 DSC curve for water structure of VP15 swollen in DX-21 with 2.0100 
EWF 
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Appendix B (Continued) 
 
Figure B-13 DSC curve for water structure of VP30 swollen in water with 1.6053 
EWF 
 
Figure B-14 DSC curve for water structure of VP30 swollen in water with 1.0348 
EWF 
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Appendix B (Continued) 
Figure B-15 DSC curve for water structure of VP30 swollen in water with 0.8266 
EWF 
 
Figure B-16 DSC curve for water structure of VP30 swollen in water with 0.5072 
EWF 
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Appendix B (Continued) 
 
Figure B-17 DSC curve for water structure of VP30 swollen in PBS with 1.8709 EWF 
 
Figure B-18 DSC curve for water structure of VP30 swollen in PBS with 1.5754 EWF 
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Appendix B (Continued) 
 
Figure B-19 DSC curve for water structure of VP30 swollen in PBS with 1.1570 EWF 
 
Figure B-20 DSC curve for water structure of VP30 swollen in PBS with0.9071 EWF 
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Appendix B (Continued) 
 
Figure B-21 DSC curve for water structure of VP30 swollen in PBS with 0.6337 EWF 
 
Figure B-22 DSC curve for water structure of VP30 swollen in DX-21 with 2.9346 
EWF 
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Appendix B (Continued) 
 
Figure B-23 DSC curve for water structure of VP30 swollen in DX-21 with 2.3633 
EWF 
 
Figure B-24 DSC curve for water structure of VP30 swollen in DX-21 with 1.5244 
EWF 
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Appendix B (Continued) 
 
Figure B-25 DSC curve for water structure of VP30 swollen in DX-21 with 1.1222 
EWF 
 
Figure B-26 DSC curve for water structure of VP30 swollen in DX-21 with 0.7178 
EWF 
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Appendix B (Continued) 
 
Figure B-27 DSC curve for water structure of VP45 swollen in water with 2.2428 
EWF 
 
Figure B-28 DSC curve for water structure of VP45 swollen in water with 1.5505 
EWF 
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Appendix B (Continued) 
 
Figure B-29 DSC curve for water structure of VP45 swollen in water with 1.2132 
EWF 
 
Figure B-30 DSC curve for water structure of VP45 swollen in water with 0.8414 
EWF 
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Appendix B (Continued) 
 
Figure B-31 DSC curve for water structure of VP45 swollen in PBS with 1.8890 EWF 
 
Figure B-32 DSC curve for water structure of VP45 swollen in PBS with 1.6677 EWF 
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Appendix B (Continued) 
 
Figure B-33 DSC curve for water structure of VP45 swollen in PBS with 1.3592 EWF 
 
Figure B-34 DSC curve for water structure of VP45 swollen in PBS with 1.2318 EWF 
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Appendix B (Continued) 
 
Figure B-35 DSC curve for water structure of VP45 swollen in PBS with 0.7746 EWF 
 
Figure B-36 DSC curve for water structure of VP45 swollen in DX-21 with 3.1004 
EWF 
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Appendix B (Continued) 
 
Figure B-37 DSC curve for water structure of VP45 swollen in DX-21 with 2.1888 
EWF 
 
Figure B-38 DSC curve for water structure of VP45 swollen in DX-21 with 2.1169 
EWF 
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Appendix B (Continued) 
 
Figure B-39 DSC curve for water structure of VP45 swollen in DX-21 with 1.8013 
EWF 
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